text:
Actin
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Actin
Ribbon diagram of G-actin. ADP bound to actin's active site (multi color sticks near center of figure) as well as a complexed calcium dication (green sphere) are highlighted.[1]
Identifiers
Symbol
Actin
Pfam
PF00022
InterPro
IPR004000
PROSITE
PDOC00340
SCOP
2btf
SUPERFAMILY
2btf
[show]Available protein structures:
Pfam
structures
PDB
RCSB PDB; PDBe; PDBj
PDBsum
structure summary
Actin is a family of globular multi-functional proteins that form microfilaments. It is found in essentially all eukaryotic cells (the only known exception being nematode sperm), where it may be present at a concentration of over 100 μM. An actin protein's mass is roughly 42-kDa, with a diameter of 4 to 7 nm, and it is the monomeric subunit of two types of filaments in cells: microfilaments, one of the three major components of the cytoskeleton, and thin filaments, part of the contractile apparatus in muscle cells. It can be present as either a free monomer called G-actin (globular) or as part of a linear polymer microfilament called F-actin (filamentous), both of which are essential for such important cellular functions as the mobility and contraction of cells during cell division.
Actin participates in many important cellular processes, including muscle contraction, cell motility, cell division and cytokinesis, vesicle and organelle movement, cell signaling, and the establishment and maintenance of cell junctions and cell shape. Many of these processes are mediated by extensive and intimate interactions of actin with cellular membranes.[2] In vertebrates, three main groups of actin isoforms, alpha, beta, and gamma have been identified. The alpha actins, found in muscle tissues, are a major constituent of the contractile apparatus. The beta and gamma actins coexist in most cell types as components of the cytoskeleton, and as mediators of internal cell motility. It is believed that the diverse range of structures formed by actin enabling it to fulfill such a large range of functions is regulated through the binding of tropomyosin along the filaments.[3]
A cell’s ability to dynamically form microfilaments provides the scaffolding that allows it to rapidly remodel itself in response to its environment or to the organism’s internal signals, for example, to increase cell membrane absorption or increase cell adhesion in order to form cell tissue. Other enzymes or organelles such as cilia can be anchored to this scaffolding in order to control the deformation of the external cell membrane, which allows endocytosis and cytokinesis. It can also produce movement either by itself or with the help of molecular motors. Actin therefore contributes to processes such as the intracellular transport of vesicles and organelles as well as muscular contraction and cellular migration. It therefore plays an important role in embryogenesis, the healing of wounds and the invasivity of cancer cells. The evolutionary origin of actin can be traced to prokaryotic cells, which have equivalent proteins.[4] Actin homologs from prokaryotes and archaea polymerize into different helical or linear filaments consisting of one or multiple strands. However the in-strand contacts and nucleotide binding sites are preserved in prokaryotes and in archaea.[5] Lastly, actin plays an important role in the control of gene expression.
A large number of illnesses and diseases are caused by mutations in alleles of the genes that regulate the production of actin or of its associated proteins. The production of actin is also key to the process of infection by some pathogenic microorganisms. Mutations in the different genes that regulate actin production in humans can cause muscular diseases, variations in the size and function of the heart as well as deafness. The make-up of the cytoskeleton is also related to the pathogenicity of intracellular bacteria and viruses, particularly in the processes related to evading the actions of the immune system.[6]
Contents
[hide]
1 Discovery and early investigation
2 Structure
2.1 G-Actin
2.2 F-Actin
2.3 Folding
2.4 ATPase’s catalytic mechanism
3 Genetics
4 Assembly dynamics
4.1 Nucleation and polymerization
4.2 Associated proteins
4.3 Chemical inhibitors
5 Functions and location
5.1 Cytoskeleton
5.1.1 Yeasts
5.1.2 Plants
5.2 Nuclear actin
5.2.1 Transport of actin through the nuclear membrane
5.2.2 The organization of nuclear actin
5.2.3 Actin isoforms in the cell nucleus
5.2.4 Nuclear actin functions
5.3 Muscular contraction
5.3.1 Outline of a muscle contraction
5.3.2 Actin’s role in muscle contraction
5.4 Other biological processes
6 Molecular pathology
6.1 Pathology associated with ACTA1
6.2 In smooth muscle
6.3 In heart muscle
6.4 In cytoplasmatic actins
6.5 Other pathological mechanisms
7 Evolution
7.1 Equivalents in bacteria
8 Applications
9 Genes
10 See also
11 References
12 External links
Discovery and early investigation[edit]
Nobel Prize winning physiologist Albert von Szent-Györgyi Nagyrápolt, co-discoverer of actin with Brunó Ferenc Straub.
Actin was first observed experimentally in 1887 by W.D. Halliburton, who extracted a protein from muscle that 'coagulated' preparations of myosin that he called "myosin-ferment".[7] However, Halliburton was unable to further refine his findings, and the discovery of actin is credited instead to Brunó Ferenc Straub, a young biochemist working in Albert Szent-Györgyi's laboratory at the Institute of Medical Chemistry at the University of Szeged, Hungary.
In 1942, Straub developed a novel technique for extracting muscle protein that allowed him to isolate substantial amounts of relatively pure actin. Straub's method is essentially the same as that used in laboratories today. Szent-Gyorgyi had previously described the more viscous form of myosin produced by slow muscle extractions as 'activated' myosin, and, since Straub's protein produced the activating effect, it was dubbed actin. Adding ATP to a mixture of both proteins (called actomyosin) causes a decrease in viscosity. The hostilities of World War II meant Szent-Gyorgyi and Straub were unable to publish the work in Western scientific journals. Actin therefore only became well known in the West in 1945, when their paper was published as a supplement to the Acta Physiologica Scandinavica.[8] Straub continued to work on actin, and in 1950 reported that actin contains bound ATP[9] and that, during polymerization of the protein into microfilaments, the nucleotide is hydrolyzed to ADP and inorganic phosphate (which remain bound to the microfilament). Straub suggested that the transformation of ATP-bound actin to ADP-bound actin played a role in muscular contraction. In fact, this is true only in smooth muscle, and was not supported through experimentation until 2001.[9][10]
The amino acid sequencing of actin was completed by M. Elzinga and co-workers in 1973.[11] The crystal structure of G-actin was solved in 1990 by Kabsch and colleagues.[12] In the same year, a model for F-actin was proposed by Holmes and colleagues following experiments using co-crystallization with different proteins.[13] The procedure of co-crystallization with different proteins was used repeatedly during the following years, until in 2001 the isolated protein was crystallized along with ADP. However, there is still no high-resolution X-ray structure of F-actin. The crystallization of F-actin was possible due to the use of a rhodamine conjugate that impedes polymerization by blocking the amino acid cys-374.[1] Christine Oriol-Audit died in the same year that actin was first crystallized but she was the researcher that in 1977 first crystallized actin in the absence of Actin Binding Proteins (ABPs). However, the resulting crystals were too small for the available technology of the time.[14]
Although no high-resolution model of actin’s filamentous form currently exists, in 2008 Sawaya’s team were able to produce a more exact model of its structure based on multiple crystals of actin dimers that bind in different places.[15] This model has subsequently been further refined by Sawaya and Lorenz. Other approaches such as the use of cryo-electron microscopy and synchrotron radiation have recently allowed increasing resolution and better understanding of the nature of the interactions and conformational changes implicated in the formation of actin filaments.[16][17][18]
Structure[edit]
Its amino acid sequence is also one of the most highly conserved of the proteins as it has changed little over the course of evolution, differing by no more than 20% in species as diverse as algae and humans.[19] It is therefore considered to have an optimised structure.[4] It has two distinguishing features: it is an enzyme that slowly hydrolizes ATP, the "universal energy currency" of biological processes. However, the ATP is required in order to maintain its structural integrity. Its efficient structure is formed by an almost unique folding process. In addition, it is able to carry out more interactions than any other protein, which allows it to perform a wider variety of functions than other proteins at almost every level of cellular life.[4] Myosin is an example of a protein that bonds with actin. Another example is villin, which can weave actin into bundles or cut the filaments depending on the concentration of calcium cations in the surrounding medium.[20]
Actin is one of the most abundant proteins in eukaryotes, where it is found throughout the cytoplasm.[20] In fact, in muscle fibres it comprises 20% of total cellular protein by weight and between 1% and 5% in other cells. However, there is not only one type of actin, the genes that code for actin are defined as a gene family (a family that in plants contains more than 60 elements, including genes and pseudogenes and in humans more than 30 elements).[4][21] This means that the genetic information of each individual contains instructions that generate actin variants (called isoforms) that possess slightly different functions. This, in turn, means that eukaryotic organisms express different genes that give rise to: α-actin, which is found in contractile structures; β-actin, found at the expanding edge of cells that use the projection of their cellular structures as their means of mobility; and γ-actin, which is found in the filaments of stress fibres.[22] In addition to the similarities that exist between an organism’s isoforms there is also an evolutionary conservation in the structure and function even between organisms contained in different eukaryotic domains: in bacteria the actin homologue MreB has been identified, which is a protein that is capable of polymerizing into microfilaments;[4][17] and in archaea the homologue Ta0583 is even more similar to the eukaryotic actins.[23]
Cellular actin has two forms: monomeric globules called G-actin and polymeric filaments called F-actin (that is, as filaments made up of many G-actin monomers). F-actin can also be described as a microfilament. Two parallel F-actin strands must rotate 166 degrees to lie correctly on top of each other. This creates the double helix structure of the microfilaments found in the cytoskeleton. Microfilaments measure approximately 7 nm in diameter with the helix repeating every 37 nm. Each molecule of actin is bound to a molecule of adenosine triphosphate (ATP) or adenosine diphosphate (ADP) that is associated with a Mg2+ cation. The most commonly found forms of actin, compared to all the possible combinations, are ATP-G-Actin and ADP-F-actin.[24][25]
G-Actin[edit]
Scanning electron microscope images indicate that G-actin has a globular structure; however, X-ray crystallography shows that each of these globules consists of two lobes separated by a cleft. This structure represents the “ATPase fold”, which is a centre of enzymatic catalysis that binds ATP and Mg2+ and hydrolyzes the former to ADP plus phosphate. This fold is a conserved structural motif that is also found in other proteins that interact with triphosphate nucleotides such as hexokinase (an enzyme used in energy metabolism) or in Hsp70 proteins (a protein family that play an important part in protein folding).[26] G-actin is only functional when it contains either ADP or ATP in its cleft but the form that is bound to ATP predominates in cells when actin is present in its free state.[24]
Ribbon model of actin extracted from the striated muscle tissue of a rabbit after Graceffa and Domínguez, 2003. The four subdomains can be seen, as well as the N and C termini and the position of the ATP bond. The molecule is oriented using the usual convention of placing the - end (pointed end) in the upper part and the + end (barbed end) in the lower part.[1]
The X-ray crystallography model of actin that was produced by Kabsch from the striated muscle tissue of rabbits is the most commonly used in structural studies as it was the first to be purified. The G-actin crystallized by Kabsch is approximately 67 x 40 x 37 Å in size, has a molecular mass of 41,785 Da and an estimated isoelectric point of 4.8. Its net charge at pH = 7 is -7.[11][27]
Primary structure
Elzinga and co-workers first determined the complete peptide sequence for this type of actin in 1973, with later work by the same author adding further detail to the model. It contains 374 amino acid residues. Its N-terminus is highly acidic and starts with an acetyled aspartate in its amino group. While its C-terminus is alkaline and is formed by a phenylalanine preceded by a cysteine, which has a degree of functional importance. Both extremes are in close proximity within the I-subdomain. An anomalous Nτ-methylhistidine is located at position 73.[27]
Tertiary structure — domains
The tertiary structure is formed by two domains known as the large and the small, which are separated by a cleft centred around the location of the bond with ATP-ADP+Pi. Below this there is a deeper notch called a “groove”. In the native state, despite their names, both have a comparable depth.[11]
The normal convention in topological studies means that a protein is shown with the biggest domain on the left-hand side and the smallest domain on the right-hand side. In this position the smaller domain is in turn divided into two: subdomain I (lower position, residues 1-32, 70-144 and 338-374) and subdomain II (upper position, residues 33-69). The larger domain is also divided in two: subdomain III (lower, residues 145-180 and 270-337) and subdomain IV (higher, residues 181-269). The exposed areas of subdomains I and III are referred to as the “barbed” ends, while the exposed areas of domains II and IV are termed the “pointed" ends. This nomenclature refers to the fact that, due to the small mass of subdomain II actin is polar; the importance of this will be discussed below in the discussion on assembly dynamics. Some authors call the subdomains Ia, Ib, IIa and IIb, respectively.[28]
Other important structures
The most notable supersecondary structure is a five chain beta sheet that is composed of a β-meander and a β-α-β clockwise unit. It is present in both domains suggesting that the protein arose from gene duplication.[12]
The adenosine nucleotide binding site is located between two beta hairpin-shaped structures pertaining to the I and III domains. The residues that are involved are Asp11-Lys18 and Asp154-His161 respectively.
The divalent cation binding site is located just below that for the adenosine nucleotide. In vivo it is most often formed by Mg2+ or Ca2+ while in vitro it is formed by a chelating structure made up of Lys18 and two oxygens from the nucleotide’s α-and β-phosphates. This calcium is coordinated with six water molecules that are retained by the amino acids Asp11, Asp154, and Gln137. They form a complex with the nucleotide that restricts the movements of the so-called "hinge" region, located between residues 137 and 144. This maintains the native form of the protein until its withdrawal denatures the actin monomer. This region is also important because it determines whether the protein’s cleft is in the "open" or "closed" conformation.[1][28]
It is highly likely that there are at least three other centres with a lesser affinity (intermediate) and still others with a low affinity for divalent cations. It has been suggested that these centres may play a role in the polymerization of actin by acting during the activation stage.[28]
There is a structure in subdomain 2 that is called the “D-loop” because it binds with DNase I, it is located between the His40 and Gly48 residues. It has the appearance of a disorderly element in the majority of crystals, but it looks like a β-sheet when it is complexed with DNase I. Domínguez “et al.” suggest that the key event in polymerization is probably the propagation of a conformational change from the centre of the bond with the nucleotide to this domain, which changes from a loop to a spiral. However, this hypothesis has been refuted by other studies.[1][29]
F-Actin[edit]
F-actin; surface representation of a repetition of 13 subunits based on Ken Holmes' actin filament model.[13]
The classical description of F-actin states that it has a filamentous structure that can be considered to be a single stranded levorotatory helix with a rotation of 166° around the helical axis and an axial translation of 27.5 Å, or a single stranded dextrorotatory helix with a cross over spacing of 350-380 Å, with each actin surrounded by four more.[30] The symmetry of the actin polymer at 2.17 subunits per turn of a helix is incompatible with the formation of crystals, which is only possible with a symmetry of exactly 2, 3, 4 or 6 subunits per turn. Therefore, models have to be constructed that explain these anomalies using data from electron microscopy, cryo-electron microscopy, crystallization of dimers in different positions and diffraction of X-rays.[17][18] It should be pointed out that it is not correct to talk of a “structure” for a molecule as dynamic as the actin filament. In reality we talk of distinct structural states, in these the measurement of axial translation remains constant at 27.5 Å while the subunit rotation data shows considerable variability, with displacements of up to 10% from its optimum position commonly seen. Some proteins, such as cofilin appear to increase the angle of turn, but again this could be interpreted as the establishment of different "structural states". These could be important in the polymerization process.[31]
There is less agreement regarding measurements of the turn radius and filament thickness: while the first models assigned a longitude of 25 Å, current X-ray diffraction data, backed up by cryo-electron microscopy suggests a longitude of 23.7 Å. These studies have shown the precise contact points between monomers. Some are formed with units of the same chain, between the "barbed" end on one monomer and the "pointed" end of the next one. While the monomers in adjacent chains make lateral contact through projections from subdomain IV, with the most important projections being those formed by the C-terminus and the hydrophobic link formed by three bodies involving residues 39-42, 201-203 and 286. This model suggests that a filament is formed by monomers in a "sheet" formation, in which the subdomains turn about themselves, this form is also found in the bacterial actin homologue MreB.[17]
The F-actin polymer is considered to have structural polarity due to the fact that all the microfilament’s subunits point towards the same end. This gives rise to a naming convention: the end that possesses an actin subunit that has its ATP binding site exposed is called the "(-) end", while the opposite end where the cleft is directed at a different adjacent monomer is called the "(+) end".[22] The terms "pointed" and "barbed" referring to the two ends of the microfilaments derive from their appearance under transmission electron microscopy when samples are examined following a preparation technique called "decoration". This method consists of the addition of myosin S1 fragments to tissue that has been fixed with tannic acid. This myosin forms polar bonds with actin monomers, giving rise to a configuration that looks like arrows with feather fletchings along its shaft, where the shaft is the actin and the fletchings are the myosin. Following this logic, the end of the microfilament that does not have any protruding myosin is called the point of the arrow (- end) and the other end is called the barbed end (+ end).[32] A S1 fragment is composed of the head and neck domains of myosin II. Under physiological conditions, G-actin (the monomer form) is transformed to F-actin (the polymer form) by ATP, where the role of ATP is essential.[33]
The helical F-actin filament found in muscles also contains a tropomyosin molecule, which is a 40 nanometre long protein that is wrapped around the F-actin helix.[18] During the resting phase the tropomyosin covers the actin’s active sites so that the actin-myosin interaction cannot take place and produce muscular contraction. There are other protein molecules bound to the tropomyosin thread, these are the troponins that have three polymers: troponin I, troponin T and troponin C.[34]
Folding[edit]
Ribbon model obtained using the PyMOL programme on crystallographs of the prefoldin proteins found in the archaean Pyrococcus horikoshii. The six supersecondary structures are present in a coiled helix “hanging” from the central beta barrels. These are often compared in the literature to the tentacles of a jellyfish. As far as is visible using electron microscopy, eukariotic prefoldin has a similar structure.[35]
Actin can spontaneously acquire a large part of its tertiary structure.[36] However, the way it acquires its fully functional form from its newly synthesized native form is special and almost unique in protein chemistry. The reason for this special route could be the need to avoid the presence of incorrectly folded actin monomers, which could be toxic as they can act as inefficient polymerization terminators. Nevertheless, it is key to establishing the stability of the cytoskeleton, and additionally, it is an essential process for coordinating the cell cycle.[37][38]
CCT is required in order to ensure that folding takes place correctly. CCT is a group II cytosolic molecular chaperone (or chaperonin, a protein that assists in the folding of other macromolecular structures). CCT is formed of a double ring of eight different subunits (hetero-octameric) and it differs from other molecular chaperones, particularly from its homologue GroEL which is found in the Archaea, as it does not require a co-chaperone to act as a lid over the central catalytic cavity. Substrates bind to CCT through specific domains. It was initially thought that it only bound with actin and tubulin, although recent immunoprecipitation studies have shown that it interacts with a large number of polypeptides, which possibly function as substrates. It acts through ATP-dependent conformational changes that on occasion require several rounds of liberation and catalysis in order to complete a reaction.[39]
In order to successfully complete their folding, both actin and tubulin need to interact with another protein called prefoldin, which is a heterohexameric complex (formed by six distinct subunits), in an interaction that is so specific that the molecules have coevolved[citation needed]. Actin complexes with prefoldin while it is still being formed, when it is approximately 145 amino acids long, specifically those at the N-terminal.[40]
Different recognition sub-units are used for actin or tubulin although there is some overlap. In actin the subunits that bind with prefoldin are probably PFD3 and PFD4, which bind in two places one between residues 60-79 and the other between residues 170-198. The actin is recognized, loaded and delivered to the cytosolic chaperonin (CCT) in an open conformation by the inner end of prefoldin’s "tentacles” (see the image and note).[36] The contact when actin is delivered is so brief that a tertiary complex is not formed, immediately freeing the prefoldin.[35]
Ribbon model of the apical γ-domain of the chaperonin CCT.
The CCT then causes actin's sequential folding by forming bonds with its subunits rather than simply enclosing it in its cavity.[41] This is why it possesses specific recognition areas in its apical β-domain. The first stage in the folding consists of the recognition of residues 245-249. Next, other determinants establish contact.[42] Both actin and tubulin bind to CCT in open conformations in the absence of ATP. In actin’s case, two subunits are bound during each conformational change, whereas for tubulin binding takes place with four subunits. Actin has specific binding sequences, which interact with the δ and β-CCT subunits or with δ-CCT and ε-CCT. After AMP-PNP is bound to CCT the substrates move within the chaperonin’s cavity. It also seems that in the case of actin, the CAP protein is required as a possible cofactor in actin's final folding states.[38]
The exact manner by which this process is regulated is still not fully understood, but it is known that the protein PhLP3 (a protein similar to phosducin) inhibits its activity through the formation of a tertiary complex.[39]
ATPase’s catalytic mechanism[edit]
Actin is an ATPase, which means that it is an enzyme that hydrolyzes ATP. This group of enzymes is characterised by their slow reaction rates. It is known that this ATPase is “active”, that is, its speed increases by some 40,000 times when the actin forms part of a filament.[31] A reference value for this rate of hydrolysis under ideal conditions is around 0.3 s−1. Then, the Pi remains bound to the actin next to the ADP for a long time, until it is liberated next to the end of the filament.[43]
The exact molecular details of the catalytic mechanism are still not fully understood. Although there is much debate on this issue, it seems certain that a "closed" conformation is required for the hydrolysis of ATP, and it is thought that the residues that are involved in the process move to the appropriate distance.[31] The glutamic acid Glu137 is one of the key residues, which is located in subdomain 1. Its function is to bind the water molecule that produces a nucleophilic attack on the ATP’s γ-phosphate bond, while the nucleotide is strongly bound to subdomains 3 and 4. The slowness of the catalytic process is due to the large distance and skewed position of the water molecule in relation to the reactant. It is highly likely that the conformational change produced by the rotation of the domains between actin’s G and F forms moves the Glu137 closer allowing its hydrolysis. This model suggests that the polymerization and ATPase’s function would be decoupled straight away.[17][18]
Genetics[edit]
Principal interactions of structural proteins are at cadherin-based adherens junction. Actin filaments are linked to α-actinin and to the membrane through vinculin. The head domain of vinculin associates to E-cadherin via α-catenin, β-catenin, and γ-catenin. The tail domain of vinculin binds to membrane lipids and to actin filaments.
Actin has been one of the most highly conserved proteins throughout evolution because it interacts with a large number of other proteins. It has 80.2% sequence conservation at the gene level between Homo sapiens and Saccharomyces cerevisiae (a species of yeast), and 95% conservation of the primary structure of the protein product.[4]
Although most yeasts have only a single actin gene, higher eukaryotes, in general, express several isoforms of actin encoded by a family of related genes. Mammals have at least six actin isoforms coded by separate genes,[44] which are divided into three classes (alpha, beta and gamma) according to their isoelectric points. In general, alpha actins are found in muscle (α-skeletal, α-aortic smooth, α-cardiac), whereas beta and gamma isoforms are prominent in non-muscle cells (β-cytoplasmic, γ1-cytoplasmic, γ2-enteric smooth). Although the amino acid sequences and in vitro properties of the isoforms are highly similar, these isoforms cannot completely substitute for one another in vivo.[45]
The typical actin gene has an approximately 100-nucleotide 5' UTR, a 1200-nucleotide translated region, and a 200-nucleotide 3' UTR. The majority of actin genes are interrupted by introns, with up to six introns in any of 19 well-characterised locations. The high conservation of the family makes actin the favoured model for studies comparing the introns-early and introns-late models of intron evolution.
All non-spherical prokaryotes appear to possess genes such as MreB, which encode homologues of actin; these genes are required for the cell's shape to be maintained. The plasmid-derived gene ParM encodes an actin-like protein whose polymerized form is dynamically unstable, and appears to partition the plasmid DNA into its daughter cells during cell division by a mechanism analogous to that employed by microtubules in eukaryotic mitosis.[46] Actin is found in both smooth and rough endoplasmic reticulums.
Assembly dynamics[edit]
Nucleation and polymerization[edit]
Thin filament formation showing the polymerization mechanism for converting G-actin to F-actin; note the hydrolysis of the ATP.
Actin polymerization and depolymerization is necessary in chemotaxis and cytokinesis. Nucleating factors are necessary to stimulate actin polymerization. One such nucleating factor is the Arp2/3 complex, which mimics a G-actin dimer in order to stimulate the nucleation (or formation of the first trimer) of monomeric G-actin. The Arp2/3 complex binds to actin filaments at 70 degrees to form new actin branches off existing actin filaments. Also, actin filaments themselves bind ATP, and hydrolysis of this ATP stimulates destabilization of the polymer.
The growth of actin filaments can be regulated by thymosin and profilin. Thymosin binds to G-actin to buffer the polymerizing process, while profilin binds to G-actin to exchange ADP for ATP, promoting the monomeric addition to the barbed, plus end of F-actin filaments.
F-actin is both strong and dynamic. Unlike other polymers, such as DNA, whose constituent elements are bound together with covalent bonds, the monomers of actin filaments are assembled by weaker bonds. The lateral bonds with neighbouring monomers resolve this anomaly, which in theory should weaken the structure as they can be broken by thermal agitation. In addition, the weak bonds give the advantage that the filament ends can easily release or incorporate monomers. This means that the filaments can be rapidly remodelled and can change cellular structure in response to an environmental stimulus. Which, along with the biochemical mechanism by which it is brought about is known as the "assembly dynamic".[6]
In vitro studies
Studies focusing on the accumulation and loss of subunits by microfilaments are carried out in vitro (that is, in the laboratory and not on cellular systems) as the polymerization of the resulting actin gives rise to the same F-actin as produced in vivo. The in vivo process is controlled by a multitude of proteins in order to make it responsive to cellular demands, this makes it difficult to observe its basic conditions.[47]
In vitro production takes place in a sequential manner: first, there is the "activation phase", when the bonding and exchange of divalent cations occurs in specific places on the G-actin, which is bound to ATP. This produces a conformational change, sometimes called G*-actin or F-actin monomer as it is very similar to the units that are located on the filament.[28] This prepares it for the "nucleation phase", in which the G-actin gives rise to small unstable fragments of F-actin that are able to polymerize. Unstable dimers and trimers are initially formed. The "elongation phase" begins when there are a sufficiently large number of these short polymers. In this phase the filament forms and rapidly grows through the reversible addition of new monomers at both extremes.[48] Finally, a "stationary equilibrium" is achieved where the G-actin monomers are exchanged at both ends of the microfilament without any change to its total length.[20] In this last phase the "critical concentration Cc" is defined as the ratio between the assembly constant and the dissociation constant for G-actin, where the dynamic for the addition and elimination of dimers and trimers does not produce a change in the microfilament's length. Under normal “in vitro” conditions Cc is 0.1 μM,[49] which means that at higher values polymerization occurs and at lower values depolymerization occurs.[50]
Role of ATP hydrolysis
As indicated above, although actin hydrolyzes ATP, everything points to the fact that ATP is not required for actin to be assembled, given that, on one hand, the hydrolysis mainly takes place inside the filament, and on the other hand the ADP could also instigate polymerization. This poses the question of understanding which thermodynamically unfavourable process requires such a prodigious expenditure of energy. The so-called “actin cycle”, which couples ATP hydrolysis to actin polymerization, consists of the preferential addition of G-actin-ATP monomers to a filament’s barbed end, and the simultaneous disassembly of F-actin-ADP monomers at the pointed end where the ADP is subsequently changed into ATP, thereby closing the cycle, this aspect of actin filament formation is known as “treadmilling”.
ATP is hydrolysed relatively rapidly just after the addition of a G-actin monomer to the filament. There are two hypotheses regarding how this occurs; the stochastic, which suggests that hydrolysis randomly occurs in a manner that is in some way influenced by the neighbouring molecules; and the vectoral, which suggests that hydrolysis only occurs adjacent to other molecules whose ATP has already been hydrolysed. In either case, the resulting Pi is not released, it remains for some time noncovalently bound to actin’s ADP, in this way there are three species of actin in a filament: ATP-Actin, ADP+Pi-Actin and ADP-Actin.[43][51] The amount of each one of these species present in a filament depends on its length and state: as elongation commences the filament has an approximately equal amount of actin monomers bound with ATP and ADP+Pi and a small amount of ADP-Actin at the (-) end. As the stationary state is reached the situation reverses, with ADP present along the majority of the filament and only the area nearest the (+) end containing ADP+Pi and with ATP only present at the tip.[52]
If we compare the filaments that only contain ADP-Actin with those that include ATP, in the former the critical constants are similar at both ends, while Cc for the other two nucleotides is different: At the (+) end Cc+=0.1 μM, while at the (-) end Cc−=0.8 μM, which gives rise to the following situations:[22]
For G-actin-ATP concentrations less than Cc+ no elongation of the filament occurs.
For G-actin-ATP concentrations less than Cc− but greater than Cc+ elongation occurs at the (+) end.
For G-actin-ATP concentrations greater than Cc− the microfilament grows at both ends.
It is therefore possible to deduce that the energy produced by hydrolysis is used to create a true “stationary state”, that is a flux, instead of a simple equilibrium, one that is dynamic, polar and attached to the filament. This justifies the expenditure of energy as it promotes essential biological functions.[43] In addition, the configuration of the different monomer types is detected by actin binding proteins, which also control this dynamism, as will be described in the following section.
Microfilament formation by treadmilling has been found to be atypical in stereocilia. In this case the control of the structure's size is totally apical and it is controlled in some way by gene expression, that is, by the total quantity of protein monomer synthesized in any given moment.[53]
Associated proteins[edit]
An actin (green) - profilin (blue) complex.[54] The profilin shown belongs to group II, normally present in the kidneys and the brain.
The actin cytoskeleton in vivo is not exclusively composed of actin, other proteins are required for its formation, continuance and function. These proteins are called actin-binding proteins (ABP) and they are involved in actin’s polymerization, depolymerization, stability, organisation in bundles or networks, fragmentation and destruction.[20] The diversity of these proteins is such that actin is thought to be the protein that takes part in the greatest number of protein-protein interactions.[55] For example, G-actin sequestering elements exist that impede its incorporation into microfilaments. There are also proteins that stimulate its polymerization or that give complexity to the synthesizing networks.[22]
Thymosin β-4 is a 5 kDa protein that can bind with G-actin-ATP in a 1:1 stoichiometry; which means that one unit of thymosin β-4 binds to one unit of G-actin. Its role is to impede the incorporation of the monomers into the growing polymer.[56]
Profilin, is a cytosolic protein with a molecular weight of 15 kDa, which also binds with G-actin-ATP or -ADP with a stoichiometry of 1:1, but it has a different function as it facilitates the replacement of ADP nucleotides by ATP. It is also implicated in other cellular functions, such as the binding of proline repetitions in other proteins or of lipids that act as secondary messengers.[57][58]
The protein gelsolin, which is a key regulator in the assembly and disassembly of actin. It has six subdomains, S1-S6, each of which is composed of a five-stranded β-sheet flanked by two α-helices, one positioned perpendicular to the strands and the other in a parallel position. Both the N-terminal end, (S1-S3), and the C-terminal end, (S4-S6), form an extended β-sheet.[59][60]
Other proteins that bind to actin regulate the length of the microfilaments by cutting them, which gives rise to new active ends for polymerization. For example, if a microfilament with two ends is cut twice, there will be three new microfilaments with six ends. This new situation favors the dynamics of assembly and disassembly. The most notable of these proteins are gelsolin and cofilin. These proteins first achieve a cut by binding to an actin monomer located in the polymer they then change the actin monomer’s conformation while remaining bound to the newly generated (+) end. This has the effect of impeding the addition or exchange of new G-actin subunits. Depolymerization is encouraged as the (-) ends are not linked to any other molecule.[61]
Other proteins that bind with actin cover the ends of F-actin in order to stabilize them, but they are unable to break them. Examples of this type of protein are CapZ (that binds the (+) ends depending on a cell’s levels of Ca2+/calmodulin. These levels depend on the cell’s internal and external signals and are involved in the regulation of its biological functions).[62] Another example is tropomodulin (that binds to the (-) end). Tropomodulin basically acts to stabilize the F-actin present in the myofibrils present in muscle sarcomeres, which are structures characterized by their great stability.[63]
Atomic structure of Arp2/3.[64] Each colour corresponds to a subunit: Arp3, orange; Arp2, sea blue (subunits 1 and 2 are not shown); p40, green; p34, light blue; p20, dark blue; p21, magenta; p16, yellow.
The Arp2/3 complex is widely found in all eukaryotic organisms.[65] It is composed of seven subunits, some of which possess a topology that is clearly related to their biological function: two of the subunits, "ARP2» and "ARP3», have a structure similar to that of actin monomers. This homology allows both units to act as nucleation agents in the polymerization of G-actin and F-actin. This complex is also required in more complicated processes such as in establishing dendritic structures and also in anastomosis (the reconnection of two branching structures that had previously been joined, such as in blood vessels).[66]
Chemical inhibitors[edit]
Chemical structure of phalloidin.
There are a number of toxins that interfere with actin’s dynamics, either by preventing it from polymerizing (latrunculin and cytochalasin D) or by stabilizing it (phalloidin):
Latrunculin is a toxin produced by sponges, it binds to G-actin preventing it from binding with microfilaments.[67]
Cytocalasin D, is an alkaloid produced by fungi, that binds to the (+) end of F-actin preventing the addition of new monomers.[68] Cytocalasin D has been found to disrupt actin’s dynamics, activating protein p53 in animals.[69]
Phalloidin, is a toxin that has been isolated from the death cap mushroom Amanita phalloides. It binds to the interface between adjacent actin monomers in the F-actin polymer, preventing its depolymerization.[68]
Functions and location[edit]
Actin forms filaments ('F-actin' or microfilaments) that are essential elements of the eukaryotic cytoskeleton, able to undergo very fast polymerization and depolymerization dynamics. In most cells actin filaments form larger-scale networks which are essential for many key functions in cells:[70]
Various types of actin networks (made of actin filaments) give mechanical support to cells, and provide trafficking routes through the cytoplasm to aid signal transduction
Rapid assembly and disassembly of actin network enables cells to migrate (Cell migration).
In metazoan muscle cells, to be the scaffold on which myosin proteins generate force to support muscle contraction
In non-muscle cells, to be a track for cargo transport myosins (nonconventional myosins) such as myosin V and VI. Nonconventional myosins use ATP hydrolysis to transport cargo, such as vesicles and organelles, in a directed fashion much faster than diffusion. Myosin V walks towards the barbed end of actin filaments, while myosin VI walks toward the pointed end. Most actin filaments are arranged with the barbed end toward the cellular membrane and the pointed end toward the cellular interior. This arrangement allows myosin V to be an effective motor for the export of cargos, and myosin VI to be an effective motor for import.
The actin protein is found in both the cytoplasm and the cell nucleus.[71] Its location is regulated by cell membrane signal transduction pathways that integrate the stimuli that a cell receives stimulating the restructuring of the actin networks in response. In Dictyostelium, phospholipase D has been found to intervene in inositol phosphate pathways.[72] Actin filaments are particularly stable and abundant in muscle fibres. Within the sarcomere (the basic morphological and physiological unit of muscle fibres) actin is present in both the I and A bands; myosin is also present in the latter.[73]
Cytoskeleton[edit]
Fluorescence micrograph showing F-actin (in green) in rat fibroblasts.
Main article: Microfilament
Microfilaments are involved in the movement of all mobile cells, including non-muscular types, and drugs that disrupt F-actin organization (such as the cytochalasins) affect the activity of these cells. Actin comprises 2% of the total amount of proteins in hepatocytes, 10% in fibroblasts, 15% in amoebas and up to 50-80% in activated platelets.[74] There are a number of different types of actin with slightly different structures and functions. This means that α-actin is found exclusively in muscle fibres, while types β and γ are found in other cells. In addition, as the latter types have a high turnover rate the majority of them are found outside permanent structures. This means that the microfilaments found in cells other than muscle cells are present in two forms:[75]
Microfilament networks - Animal cells commonly have a cell cortex under the cell membrane that contains a large number of microfilaments, which precludes the presence of organelles. This network is connected with numerous receptor cells that relay signals to the outside of a cell.
A merged stack of confocal images showing actin filaments within a cell. The image has been colour coded in the z axis to show in a 2D image which heights filaments can be found at within cells.
Microfilament bundles - These extremely long microfilaments are located in networks and, in association with contractile proteins such as non-muscular myosin, they are involved in the movement of substances at an intracellular level.
Periodic actin rings - A periodic structure constructed of evenly spaced actin rings is recently found to specifically exist in axons (not dendrites).[76] In this structure, the actin rings, together with spectrin tetramers that link the neighboring actin rings, form a cohesive cytoskeleton that supports the axon membrane. The structure periodicity may also regulate the sodium ion channels in axons.
Yeasts[edit]
Actin’s cytoskeleton is key to the processes of endocytosis, cytokinesis, determination of cell polarity and morphogenesis in yeasts. In addition to relying on actin these processes involve 20 or 30 associated proteins, which all have a high degree of evolutionary conservation, along with many signalling molecules. Together these elements allow a spatially and temporally modulated assembly that defines a cell’s response to both internal and external stimuli.[77]
Yeasts contain three main elements that are associated with actin: patches, cables and rings that, despite being present for long, are subject to a dynamic equilibrium due to continual polymerization and depolymerization. They possess a number of accessory proteins including ADF/cofilin, which has a molecular weight of 16kDa and is coded for by a single gene, called COF1; Aip1, a cofilin cofactor that promotes the disassembly of microfilaments; Srv2/CAP, a process regulator related to adenylate cyclase proteins; a profilin with a molecular weight of approximately 14 kDa that is associated with actin monomers; and twinfilin, a 40 kDa protein involved in the organization of patches.[77]
Plants[edit]
Plant genome studies have revealed the existence of protein isovariants within the actin family of genes. Within Arabidopsis thaliana, a dicotyledon used as a model organism, there are ten types of actin, nine types of α-tubulins, six β-tubulins, six profilins and dozens of myosins. This diversity is explained by the evolutionary necessity of possessing variants that slightly differ in their temporal and spatial expression.[4] The majority of these proteins were jointly expressed in the tissue analysed. Actin networks are distributed throughout the cytoplasm of cells that have been cultivated in vitro. There is a concentration of the network around the nucleus that is connected via spokes to the cellular cortex, this network is highly dynamic, with a continuous polymerization and depolymerization.[78]
Structure of the C-terminal subdomain of villin, a protein capable of splitting microfilaments.[79]
Even though the majority of plant cells have a cell wall that defines their morphology and impedes their movement, their microfilaments can generate sufficient force to achieve a number of cellular activities, such as, the cytoplasmic currents generated by the microfilaments and myosin. Actin is also involved in the movement of organelles and in cellular morphogenesis, which involve cell division as well as the elongation and differentiation of the cell.[80]
The most notable proteins associated with the actin cytoskeleton in plants include:[80] villin, which belongs to the same family as gelsolin/severin and is able to cut microfilaments and bind actin monomers in the presence of calcium cations; fimbrin, which is able to recognize and unite actin monomers and which is involved in the formation of networks (by a different regulation process from that of animals and yeasts);[81] formins, which are able to act as an F-actin polymerization nucleating agent; myosin, a typical molecular motor that is specific to eukaryotes and which in Arabidopsis thaliana is coded for by 17 genes in two distinct classes; CHUP1, which can bind actin and is implicated in the spatial distribution of chloroplasts in the cell; KAM1/MUR3 that define the morphology of the Golgi apparatus as well as the composition of xyloglucans in the cell wall; NtWLIM1, which facilitates the emergence of actin cell structures; and ERD10, which is involved in the association of organelles within membranes and microfilaments and which seems to play a role that is involved in an organism’s reaction to stress.
Nuclear actin[edit]
Nuclear actin was first noticed and described in 1977 by Clark and Merriam.[82] Authors describe a protein present in the nuclear fraction, obtained from Xenopus laevis oocytes, which shows the same features such skeletal muscle actin. Since that time there have been many scientific reports about the structure and functions of actin in the nucleus (for review see: Hofmann 2009.[83]) The controlled level of actin in the nucleus, its interaction with actin-binding proteins (ABP) and the presence of different isoforms allows actin to play an important role in many important nuclear processes.
Transport of actin through the nuclear membrane[edit]
The actin sequence does not contain a nuclear localization signal. The small size of actin (about 43 kDa) allows it to enter the nucleus by passive diffusion.[84] Actin however shuttles between cytoplasm and nucleus quite quickly, which indicates the existence of active transport. The import of actin into the nucleus (probably in a complex with cofilin) is facilitated by the import protein importin 9.[85]
Low level of actin in the nucleus seems to be very important, because actin has two nuclear export signals (NES) into its sequence. Microinjected actin is quickly removed from the nucleus to the cytoplasm. Actin is exported at least in two ways, through exportin 1 (EXP1) and exportin 6 (Exp6).[86][87]
Specific modifications, such as SUMOylation, allows for nuclear actin retention. It was demonstrated that a mutation preventing SUMOylation causes rapid export of beta actin from the nucleus.[88]
Based on the experimental results a general mechanism of nuclear actin transport can be proposed:[88][89]
In the cytoplasm cofilin bind ADP-actin monomers. This complex is actively imported into the nucleus.
Higher concentration of ATP in the nucleus (compared to the cytoplasm) promote ADP to ATP exchange in the actin-cofilin complex. This weakens the strength of binding of these two proteins.
Cofilin-actin complex finally dissociate after cofilin phosphorylation by nuclear LIM kinase.
Actin is SUMOylated and in this form retain inside nucleus.
Actin can form complexes with profilin and leave the nucleus via exportin 6.
The organization of nuclear actin[edit]
Nuclear actin exists mainly as a monomer, but can also form dynamic oligomers and short polymers.[90][91][92] Nuclear actin organization varies in different cell types. For example, in Xenopus oocytes (with higher nuclear actin level in comparison to somatic cells) actin forms filaments, which stabilize nucleus architecture. These filaments can be observed under the microscope thanks to fluorophore-conjugated phalloidin staining.[82][84]
In somatic cell nucleus however we cannot observe any actin filaments using this technique.[93] The DNase I inhibition assay, so far the only test which allows the quantification of the polymerized actin directly in biological samples, have revealed that endogenous nuclear actin occurs indeed mainly in a monomeric form.[92]
Precisely controlled level of actin in the cell nucleus, lower than in the cytoplasm, prevents the formation of filaments. The polymerization is also reduced by the limited access to actin monomers, which are bound in complexes with ABPs, mainly cofilin.[89]
Actin isoforms in the cell nucleus[edit]
Little attention is paid to actin isoforms, however it has been shown that different isoforms of actin are present in the cell nucleus. Actin isoforms, despite of their high sequence similarity, have different biochemical properties such as polymerization and depolymerization kinetic.[94] They also shows different localization and functions.
The level of actin isoforms, both in the cytoplasm and the nucleus, may change for example in response to stimulation of cell growth or arrest of proliferation and transcriptional activity.[95]
Research concerns on nuclear actin are usually focused on isoform beta.[96][97][98][99] However the use of antibodies directed against different actin isoforms allows identifying not only the cytoplasmic beta in the cell nucleus, but also:
gamma actin in the cell nuclei of human melanoma,[92]
alpha skeletal muscle actin in the nuclei of mouse myoblasts,[100]
cytoplasmic gamma actin and also alpha smooth muscle actin in the nucleus of the foetal mouse fibroblast[101]
The presence of different isoforms of actin may have a significant effect on its function in nuclear processes, especially because the level of individual isoforms can be controlled independently.[92]
Nuclear actin functions[edit]
Functions of actin in the nucleus are associated with its ability to polymerization, interaction with variety of ABPs and with structural elements of the nucleus. Nuclear actin is involved in:
Architecture of the nucleus - interaction of actin with alpha II-spectrin and other proteins are important for maintaining proper shape of the nucleus[102][103]
Transcription – actin is involved in chromatin reorganization.[71][96][104][105] transcription initiation and interacts with transcription complex.[106] Actin takes part in the regulation of chromatin structure[107][108][109] interact with both the RNA polymerase I,[99] II[97] and III[98] In Pol I transcription, actin and myosin (MYO1C, which binds DNA) act as a molecular motor. For Pol II transcription, β-actin is needed for the formation of the preinitiation complex. Pol III contains β-actin as a subunit. Actin can also be a component of chromatin remodelling complexes as well as pre-mRNP particles (that is, precursor messenger RNA bundled in proteins), and is involved in nuclear export of RNAs and proteins.[110]
Regulation of gene activity – actin binds to the regulatory regions of different kinds of genes[111][112][113][114] Actin ability to regulate gene activity is used in the molecular reprogramming method, which allows differentiated cells return to their embryonic state[113][115]
Translocation of the activated chromosome fragment from under membrane region to euchromatin where transcription starts. The movement require the interaction of actin and myosin[116][117]
Integration of different cellular compartments. Actin is a molecule that integrates cytoplasmic and nuclear signal transduction pathway.[118] An example is the activation of transcription in response to serum stimulation of cells in vitro.[119][120][121]
Due to its ability to conformational changes and interaction with many proteins actin acts as a regulator of formation and activity of protein complexes such as transcriptional complex.[106]
Muscular contraction[edit]
Main article: Muscular contraction
The structure of a sarcomere, the basic morphological and functional unit of the skeletal muscles that contains actin.
Outline of a muscle contraction[edit]
In muscle cells, actomyosin myofibrils makeup much of the cytoplasmic material. These myofibrils are made of thin filaments of actin (typically around 7 nm in diameter), and thick filaments of the motor-protein myosin (typically around 15 nm in diameter).[122] These myofibrils use energy derived from ATP to create movements of cells, such as muscle contraction.[122] Using the hydrolysis of ATP for energy, myosin heads undergo a cycle during which they attach to thin filaments, exert a tension, and then, depending on the load, perform a power stroke that causes the thin filaments to slide past, shortening the muscle.
In contractile bundles, the actin-bundling protein alpha-actinin separates each thin filament by ~35 nm. This increase in distance allows thick filaments to fit in between and interact, enabling deformation or contraction. In deformation, one end of myosin is bound to the plasma membrane, while the other end "walks" toward the plus end of the actin filament. This pulls the membrane into a different shape relative to the cell cortex. For contraction, the myosin molecule is usually bound to two separate filaments and both ends simultaneously "walk" toward their filament's plus end, sliding the actin filaments closer to each other. This results in the shortening, or contraction, of the actin bundle (but not the filament). This mechanism is responsible for muscle contraction and cytokinesis, the division of one cell into two.
Actin’s role in muscle contraction[edit]
The helical F-actin filament found in muscles also contains a tropomyosin molecule, a 40-nanometre protein that is wrapped around the F-actin helix. During the resting phase the tropomyosin covers the actin’s active sites so that the actin-myosin interaction cannot take place and produce muscular contraction (the interaction gives rise to a movement between the two proteins that, because it is repeated many times, produces a contraction). There are other protein molecules bound to the tropomyosin thread, these include the troponins that have three polymers: troponin I, troponin T, and troponin C.[34] Tropomyosin’s regulatory function depends on its interaction with troponin in the presence of Ca2+ ions.[123]
Both actin and myosin are involved in muscle contraction and relaxation and they make up 90% of muscle protein.[124] The overall process is initiated by an external signal, typically through an action potential stimulating the muscle, which contains specialized cells whose interiors are rich in actin and myosin filaments. The contraction-relaxation cycle comprises the following steps:[73]
Depolarization of the sarcolemma and transmission of an action potential through the T-tubules.
Opening of the sarcoplasmic reticulum’s Ca2+ channels.
Increase in cytosolic Ca2+ concentrations and the interaction of these cations with troponin causing a conformational change in its structure. This in turn alters the structure of tropomyosin, which covers actin’s active site, allowing the formation of myosin-actin cross-links (the latter being present as thin filaments).[34]
Movement of myosin heads over the thin filaments, this can either involve ATP or be independent of ATP. The former mechanism, mediated by ATPase activity in the myosin heads, causes the movement of the actin filaments towards the Z-disc.
Ca2+ capture by the sarcoplasmic reticulum, causing a new conformational change in tropomyosin that inhibits the actin-myosin interaction.[124]
Other biological processes[edit]
Play media
Fluorescence imaging of actin dynamics during the first embryonic cell division of C. elegans. First, actin filaments assemble in the upper part of the cell, thus contributing to asymmetric cell division. Then, at 10 s, formation of the contractile actin ring can be observed.
The traditional image of actin’s function relates it to the maintenance of the cytoskeleton and, therefore, the organization and movement of organelles, as well as the determination of a cell’s shape.[75] However, actin has a wider role in eukaryotic cell physiology, in addition to similar functions in prokaryotes.
Cytokinesis. Cell division in animal cells and yeasts normally involves the separation of the parent cell into two daughter cells through the constriction of the central circumference. This process involves a constricting ring composed of actin, myosin, and α-actinin.[125] In the "fission yeast” Schizosaccharomyces pombe, actin is actively formed in the constricting ring with the participation of Arp3, the formin Cdc12, profilin, and WASp, along with preformed microfilaments. Once the ring has been constructed the structure is maintained by a continual assembly and disassembly that, aided by the Arp2/3 complex and formins, is key to one of the central processes of cytokinesis.[126] The totality of the contractile ring, the spindle apparatus, microtubules and the dense peripheral material is called the "Fleming body» or "intermediate body».[75]
Apoptosis. During programmed cell death the ICE/ced-3 family of proteases (one of the interleukin-1β-converter proteases) degrade actin into two fragments “in vivo”; one of the fragments is 15 kDa and the other 31 kDa. This represents one of the mechanisms involved in destroying cell viability that form the basis of apoptosis.[127] The protease calpain has also been shown to be involved in this type of cell destruction;[128] just as the use of calpain inhibitors has been shown to decrease actin proteolysis and the degradation of DNA (another of the characteristic elements of apoptosis).[129] On the other hand, the stress-induced triggering of apoptosis causes the reorganization of the actin cytoskeleton (which also involves its polymerization), giving rise to structures called stress fibers; this is activated by the MAP kinase pathway.[130]
Diagram of a zonula occludens or tight junction, a structure that joins the epithelium of two cells. Actin is one of the anchoring elements shown in green.
Cellular adhesion and development. The adhesion between cells is a characteristic of multicellular organisms that enables tissue specialization and therefore increases cell complexity. Adhesion of cell epithelia involves the actin cytoskeleton in each of the joined cells as well as cadherins acting as extracellular elements with the connection between the two mediated by catenins.[131] Interfering in actin dynamics has repercussions for an organism’s development, in fact actin is such a crucial element that systems of redundant genes are available. For example, if the α-actinin or gelation factor gene has been removed in Dictyostelium individuals do not show an anomalous phenotype possibly due to the fact that each of the proteins can perform the function of the other. However, the development of double mutations that lack both gene types is affected.[132]
Gene expression modulation. Actin’s state of polymerization affects the pattern of gene expression. In 1997, it was discovered that cytocalasin D-mediated depolymerization in Schwann cells causes a specific pattern of expression for the genes involved in the myelinization of this type of nerve cell.[133] F-actin has been shown to modify the transcriptome in some of the life stages of unicellular organisms, such as the fungus Candida albicans.[134] In addition, proteins that are similar to actin play a regulatory role during spermatogenesis in mice[135] and, in yeasts, actin-like proteins are thought to play a role in the regulation of gene expression.[136] In fact, actin is capable of acting as a transcription initiator when it reacts with a type of nuclear myosin that interacts with RNA polymerases and other enzymes involved in the transcription process.[71]
Stereocilia dynamics. Some cells develop fine filliform outgrowths on their surface that have a mechanosensory function. For example, this type of organelle is present in the Organ of Corti, which is located in the ear. The main characteristic of these structures is that their length can be modified.[137] The molecular architecture of the stereocilia includes a paracrystalline actin core in dynamic equilibrium with the monomers present in the adjacent cytosol. Type VI and VIIa myosins are present throughout this core, while myosin XVa is present in its extremities in quantities that are proportional to the length of the stereocilia.[138]
Intrinsic chirality. Actomyosin networks have been implicated in generating an intrinsic chirality in individual cells.[139] Cells grown out on chiral surfaces can show a directional left/right bias that is actomyosin dependent.[140][141]
Molecular pathology[edit]
The majority of mammals possess six different actin genes. Of these, two code for the cytoskeleton (ACTB and ACTG1) while the other four are involved in skeletal striated muscle (ACTA1), smooth muscle tissue (ACTA2), intestinal muscles (ACTG2) and cardiac muscle (ACTC1). The actin in the cytoskeleton is involved in the pathogenic mechanisms of many infectious agents, including HIV. The vast majority of the mutations that affect actin are point mutations that have a dominant effect, with the exception of six mutations involved in nemaline myopathy. This is because in many cases the mutant of the actin monomer acts as a “cap” by preventing the elongation of F-actin.[28]
Pathology associated with ACTA1[edit]
ACTA1 is the gene that codes for the α-isoform of actin that is predominant in human skeletal striated muscles, although it is also expressed in heart muscle and in the thyroid gland.[142] Its DNA sequence consists of seven exons that produce five known transcripts.[143] The majority of these consist of point mutations causing substitution of amino acids. The mutations are in many cases associated with a phenotype that determines the severity and the course of the affliction.[28][143]
Giant nemaline rods produced by the transfection of a DNA sequence of ACTA1, which is the carrier of a mutation responsible for nemaline myopathy.[144]
The mutation alters the structure and function of skeletal muscles producing one of three forms of myopathy: type 3 nemaline myopathy, congenital myopathy with an excess of thin myofilaments (CM) and Congenital myopathy with fibre type disproportion (CMFTD). Mutations have also been found that produce “core” myopathies).[145] Although their phenotypes are similar, in addition to typical nemaline myopathy some specialists distinguish another type of myopathy called actinic nemaline myopathy. In the former, clumps of actin form instead of the typical rods. It is important to state that a patient can show more than one of these phenotypes in a biopsy.[146] The most common symptoms consist of a typical facial morphology (myopathic faces), muscular weakness, a delay in motor development and respiratory difficulties. The course of the illness, its gravity and the age at which it appears are all variable and overlapping forms of myopathy are also found. A symptom of nemalinic myopathy is that “Nemaline rods” appear in differing places in Type 1 muscle fibres. These rods are non-pathognomonic structures that have a similar composition to the Z disks found in the sarcomere.[147]
The pathogenesis of this myopathy is very varied. Many mutations occur in the region of actin’s indentation near to its nucleotide binding sites, while others occur in Domain 2, or in the areas where interaction occurs with associated proteins. This goes some way to explain the great variety of clumps that form in these cases, such as Nemaline or Intranuclear Bodies or Zebra Bodies.[28] Changes in actin’s folding occur in nemaline myopathy as well as changes in its aggregation and there are also changes in the expression of other associated proteins. In some variants where intranuclear bodies are found the changes in the folding masks the nucleus’s protein exportation signal so that the accumulation of actin's mutated form occurs in the cell nucleus.[148] On the other hand, it appears that mutations to ACTA1 that give rise to a CFTDM have a greater effect on sarcomeric function than on its structure.[149] Recent investigations have tried to understand this apparent paradox, which suggests there is no clear correlation between the number of rods and muscular weakness. It appears that some mutations are able to induce a greater apoptosis rate in type II muscular fibres.[37]
Position of seven mutations relevant to the various actinopathies related to ACTA1.[144]
In smooth muscle[edit]
There are two isoforms that code for actins in the smooth muscle tissue:
ACTG2 codes for the largest actin isoform, which has nine exons, one of which, the one located at the 5' end, is not translated.[150] It is an γ-actin that is expressed in the enteric smooth muscle. No mutations to this gene have been found that correspond to pathologies, although microarrays have shown that this protein is more often expressed in cases that are resistant to chemotherapy using cisplatin.[151]
ACTA2 codes for an α-actin located in the smooth muscle, and also in vascular smooth muscle. It has been noted that the MYH11 mutation could be responsible for at least 14% of hereditary thoracic aortic aneurisms particularly Type 6. This is because the mutated variant produces an incorrect filamentary assembly and a reduced capacity for vascular smooth muscle contraction. Degradation of the aortic media has been recorded in these individuals, with areas of disorganization and hyperplasia as well as stenosis of the aorta’s vasa vasorum.[152] The number of afflictions that the gene is implicated in is increasing. It has been related to Moyamoya disease and it seems likely that certain mutations in heterozygosis could confer a predisposition to many vascular pathologies, such as thoracic aortic aneurysm and ischaemic heart disease.[153] The α-actin found in smooth muscles is also an interesting marker for evaluating the progress of liver cirrhosis.[154]
In heart muscle[edit]
The ACTC1 gene codes for the α-actin isoform present in heart muscle. It was first sequenced by Hamada and co-workers in 1982, when it was found that it is interrupted by five introns.[155] It was the first of the six genes where alleles were found that were implicated in pathological processes.[156]
Crossection of a rat heart that is showing signs of dilated cardiomyopathy.[157]
A number of structural disorders associated with point mutations of this gene have been described that cause malfunctioning of the heart, such as Type 1R dilated cardiomyopathy and Type 11 hypertrophic cardiomyopathy. Certain defects of the atrial septum have been described recently that could also be related to these mutations.[158][159]
Two cases of dilated cardiomyopathy have been studied involving a substitution of highly conserved amino acids belonging to the protein domains that bind and intersperse with the Z discs. This has led to the theory that the dilation is produced by a defect in the transmission of contractile force in the myocytes.[30][156]
The mutations in”ACTC1” are responsible for at least 5% of hypertrophic cardiomyopathies.[160] The existence of a number of point mutations have also been found:[161]
Mutation E101K: changes of net charge and formation of a weak electrostatic link in the actomyosin-binding site.
P166A: interaction zone between actin monomers.
A333P: actin-myosin interaction zone.
Pathogenesis appears to involve a compensatory mechanism: the mutated proteins act like “toxins” with a dominant effect, decreasing the heart’s ability to contract causing abnormal mechanical behaviour such that the hypertrophy, that is usually delayed, is a consequence of the cardiac muscle’s normal response to stress.[162]
Recent studies have discovered “ACTC1” mutations that are implicated in two other pathological processes: Infantile idiopathic restrictive cardiomyopathy,[163] and noncompaction of the left ventricular myocardium.[164]
In cytoplasmatic actins[edit]
ACTB is a highly complex locus. A number of pseudogenes exist that are distributed throughout the genome, and its sequence contains six exons that can give rise to up to 21 different transcriptions by alternative splicing, which are known as the β-actins. Consistent with this complexity, its products are also found in a number of locations and they form part of a wide variety of processes (cytoskeleton, NuA4 histone-acyltransferase complex, cell nucleus) and in addition they are associated with the mechanisms of a great number of pathological processes (carcinomas, juvenile dystonia, infection mechanisms, nervous system malformations and tumour invasion, among others).[165] A new form of actin has been discovered, kappa actin, which appears to substitute for β-actin in processes relating to tumours.[166]
Image taken using confocal microscopy and employing the use of specific antibodies showing actin’s cortical network. In the same way that in juvenile dystonia there is an interruption in the structures of the cytoskeleton, in this case it is produced by cytochalasin D.[167]
Three pathological processes have so far been discovered that are caused by a direct alteration in gene sequence:
Hemangiopericytoma with t(7;12)(p22;q13)-translocations is a rare affliction, in which a translocational mutation causes the fusion of the ACTB gene over GLI1 in Chromosome 12.[168]
Juvenile onset dystonia is a rare degenerative disease that affects the central nervous system; in particular, it affects areas of the neocortex and thalamus, where rod-like eosinophilic inclusions are formed. The affected individuals represent a phenotype with deformities on the median line, sensory hearing loss and dystonia. It is caused by a point mutation in which the amino acid tryptophan replaces arginine in position 183. This alters actin’s interaction with the ADF/cofilin system, which regulates the dynamics of nerve cell cytoskeleton formation.[169]
A dominant point mutation has also been discovered that causes neutrophil granulocyte dysfunction and recurring infections. It appears that the mutation modifies the domain responsible for binding between profilin and other regulatory proteins. Actin’s affinity for profilin is greatly reduced in this allele.[170]
The ACTG1 locus codes for the cytosolic γ-actin protein that is responsible for the formation of cytoskeletal microfilaments. It contains six exons, giving rise to 22 different mRNAs, which produce four complete isoforms whose form of expression is probably dependent on the type of tissue they are found in. It also has two different DNA promoters.[171] It has been noted that the sequences translated from this locus and from that of β-actin are very similar to the predicted ones, suggesting a common ancestral sequence that suffered duplication and genetic conversion.[172]
In terms of pathology, it has been associated with processes such as amyloidosis, retinitis pigmentosa, infection mechanisms, kidney diseases and various types of congenital hearing loss.[171]
Six autosomal-dominant point mutations in the sequence have been found to cause various types of hearing loss, particularly sensorineural hearing loss linked to the DFNA 20/26 locus. It seems that they affect the stereocilia of the ciliated cells present in the inner ear’s Organ of Corti. β-actin is the most abundant protein found in human tissue, but it is not very abundant in ciliated cells, which explains the location of the pathology. On the other hand, it appears that the majority of these mutations affect the areas involved in linking with other proteins, particularly actomyosin.[28] Some experiments have suggested that the pathological mechanism for this type of hearing loss relates to the F-actin in the mutations being more sensitive to cofilin than normal.[173]
However, although there is no record of any case, it is known that γ-actin is also expressed in skeletal muscles, and although it is present in small quantities, model organisms have shown that its absence can give rise to myopathies.[174]
Other pathological mechanisms[edit]
Some infectious agents use actin, especially cytoplasmic actin, in their life cycle. Two basic forms are present in bacteria:
Listeria monocytogenes, some species of Rickettsia, Shigella flexneri and other intracellular germs escape from phagocytic vacuoles by coating themselves with a capsule of actin filaments. L. monocytogenes and S. flexneri both generate a tail in the form of a "comet tail" that gives them mobility. Each species exhibits small differences in the molecular polymerization mechanism of their "comet tails». Different displacement velocities have been observed, for example, with Listeria and Shigella found to be the fastest.[175] Many experiments have demonstrated this mechanism in vitro. This indicates that the bacteria are not using a myosin-like protein motor, and it appears that their propulsion is acquired from the pressure exerted by the polymerization that takes place near to the microorganism's cell wall. The bacteria have previously been surrounded by ABPs from the host, and as a minimum the covering contains Arp2/3 complex, Ena/VASP proteins, cofilin, a buffering protein and nucleation promoters, such as vinculin complex. Through these movements they form protrusions that reach the neighbouring cells, infecting them as well so that the immune system can only fight the infection through cell immunity. The movement could be caused by the modification of the curve and debranching of the filaments.[176] Other species, such as Mycobacterium marinum and Burkholderia pseudomallei, are also capable of localized polymerization of cellular actin to aid their movement through a mechanism that is centered on the Arp2/3 complex. In addition the vaccine virus Vaccinia also uses elements of the actin cytoskeleton for its dissemination.[177]
Pseudomonas aeruginosa is able to form a protective biofilm in order to escape a host organism’s defences, especially white blood cells and antibiotics. The biofilm is constructed using DNA and actin filaments from the host organism.[178]
In addition to the previously cited example, actin polymerization is stimulated in the initial steps of the internalization of some viruses, notably HIV, by, for example, inactivating the cofilin complex.[179]
The role that actin plays in the invasion process of cancer cells has still not been determined.[180]
Evolution[edit]
The eukaryotic cytoskeleton of organisms among all taxonomic groups have similar components to actin and tubulin. For example, the protein that is coded by the ACTG2 gene in humans is completely equivalent to the homologues present in rats and mice, even though at a nucleotide level the similarity decreases to 92%.[150] However, there are major differences with the equivalents in prokaryotes (FtsZ and MreB), where the similarity between nucleotide sequences is between 40−50 % among different bacteria and archaea species. Some authors suggest that the ancestral protein that gave rise to the model eukaryotic actin resembles the proteins present in modern bacterial cytoskeletons.[4][181]
Structure of MreB, a bacterial protein whose three-dimensional structure resembles that of G-actin.
Some authors point out that the behaviour of actin, tubulin and histone, a protein involved in the stabilization and regulation of DNA, are similar in their ability to bind nucleotides and in their ability of take advantage of Brownian motion. It has also been suggested that they all have a common ancestor.[182] Therefore, evolutionary processes resulted in the diversification of ancestral proteins into the varieties present today, conserving, among others, actins as efficient molecules that were able to tackle essential ancestral biological processes, such as endocytosis.[183]
Equivalents in bacteria[edit]
The bacterial cytoskeleton may not be as complex as that found in eukaryotes; however, it contains proteins that are highly similar to actin monomers and polymers. The bacterial protein MreB polymerizes into thin non-helical filaments and occasionally into helical structures similar to F-actin.[17][184] Furthermore, its crystalline structure is very similar to that of G-actin (in terms of its three-dimensional conformation), there are even similarities between the MreB protofilaments and F-actin. The bacterial cytoskeleton also contains the FtsZ proteins, which are similar to tubulin.[185]
Bacteria therefore possess a cytoskeleton with homologous elements to actin (for example, MreB, ParM, and MamK), even though the amino acid sequence of these proteins diverges from that present in animal cells. However, MreB and ParM have a high degree of structural similarity to eukaryotic actin. The highly dynamic microfilaments formed by the aggregation of MreB and ParM are essential to cell viability and they are involved in cell morphogenesis, chromosome segregation, and cell polarity. ParM is an actin homologue that is coded in a plasmid and it is involved in the regulation of plasmid DNA.[4][186] ParMs from different bacterial plasmids can form astonishingly diverse helical structures comprising two[187][188] or four[189] strands to maintain faithful plasmid inheritance.
Applications[edit]
Actin is used in scientific and technological laboratories as a track for molecular motors such as myosin (either in muscle tissue or outside it) and as a necessary component for cellular functioning. It can also be used as a diagnostic tool, as several of its anomalous variants are related to the appearance of specific pathologies.
Nanotechnology. Actin-myosin systems act as molecular motors that permit the transport of vesicles and organelles throughout the cytoplasm. It is possible that actin could be applied to nanotechnology as its dynamic ability has been harnessed in a number of experiments including those carried out in acellular systems. The underlying idea is to use the microfilaments as tracks to guide molecular motors that can transport a given load. That is actin could be used to define a circuit along which a load can be transported in a more or less controlled and directed manner. In terms of general applications, it could be used for the directed transport of molecules for deposit in determined locations, which would permit the controlled assembly of nanostructures.[190] These attributes could be applied to laboratory processes such as on lab-on-a-chip, in nanocomponent mechanics and in nanotransformers that convert mechanical energy into electrical energy.[191]
Internal control of techniques used in molecular biology, such as western blot and quantitative PCR. As actin is essential for cell survival it has been postulated that the quantity of actin is under such tight control at a cellular level that it can be assumed that its transcription (that is, the degree to which its genes are expressed) and translation, that is the production of protein, is practically constant and independent of experimental conditions. Therefore, it is common practice in protein quantification studies (western blot) and transcription studies (quantitative PCR) to carry out the quantification of the gene of interest and also the quantification of a reference gene such as the one that codes for actin. By dividing the quantity of the gene of interest by that of the actin gene it is possible to obtain a relative quantity that can be compared between different experiments,[192] whenever the expression of the latter is constant. It is worth pointing out that actin does not always have the desired stability in its gene expression.[193]
Health. Some alleles of actin cause diseases; for this reason techniques for their detection have been developed. In addition, actin can be used as an indirect marker in surgical pathology: it is possible to use variations in the pattern of its distribution in tissue as a marker of invasion in neoplasia, vasculitis, and other conditions.[194] Further, due to actin’s close association with the apparatus of muscular contraction its levels in skeletal muscle diminishes when these tissues atrophy, it can therefore be used as a marker of this physiological process.[195]
Food technology. It is possible to determine the quality of certain processed foods, such as sausages, by quantifying the amount of actin present in the constituent meat. Traditionally, a method has been used that is based on the detection of 3-methylhistidine in hydrolyzed samples of these products, as this compound is present in actin and F-myosin’s heavy chain (both are major components of muscle). The generation of this compound in flesh derives from the methylation of histidine residues present in both proteins.[196][197]
Genes[edit]
Human genes encoding actin proteins include:
ACTA1 — alpha actin 1, skeletal muscle
ACTA2 — alpha actin 2, smooth muscle, aorta
ACTB — beta actin
ACTC1 — actin, alpha, cardiac muscle 1
ACTG1 — gamma actin 1
ACTG2 — gamma actin 2, smooth muscle, enteric
See also[edit]
Actin remodeling — effect on cell structure and shape
Actin-binding protein
Active matter
Arp2/3
Filopodia
FtsZ
Intermediate filament
Lamellipodium
Motor protein — converts chemical energy into mechanical work
MreB — one of the actin homologues in bacteria
Phallotoxin
References[edit]
^ Jump up to: a b c d e PDB: 1J6Z; Otterbein LR, Graceffa P, Dominguez R (Jul 2001). "The crystal structure of uncomplexed actin in the ADP state". Science. 293 (5530): 708–11. PMID 11474115. doi:10.1126/science.1059700.
Jump up ^ Doherty GJ, McMahon HT (2008). "Mediation, modulation, and consequences of membrane-cytoskeleton interactions". Annual Review of Biophysics. 37 (1): 65–95. PMID 18573073. doi:10.1146/annurev.biophys.37.032807.125912.
Jump up ^ Vindin H, Gunning P (Aug 2013). "Cytoskeletal tropomyosins: choreographers of actin filament functional diversity". Journal of Muscle Research and Cell Motility. 34 (3–4): 261–74. PMC 3843815  . PMID 23904035. doi:10.1007/s10974-013-9355-8.
^ Jump up to: a b c d e f g h i Gunning PW, Ghoshdastider U, Whitaker S, Popp D, Robinson RC (Jun 2015). "The evolution of compositionally and functionally distinct actin filaments". Journal of Cell Science. 128 (11): 2009–19. PMID 25788699. doi:10.1242/jcs.165563.
Jump up ^ Ghoshdastider U, Jiang S, Popp D, Robinson RC (Jul 2015). "In search of the primordial actin filament". Proceedings of the National Academy of Sciences of the United States of America. 112 (30): 9150–1. PMC 4522752  . PMID 26178194. doi:10.1073/pnas.1511568112.
^ Jump up to: a b Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002). "Chapter 16: The cytoskeleton". Molecular biology of the cell. New York: Garland Science. pp. 907–982. ISBN 0-8153-3218-1.
Jump up ^ Halliburton WD (Aug 1887). "On Muscle-Plasma". The Journal of Physiology. 8 (3–4): 133–202. PMC 1485127  . PMID 16991477. doi:10.1113/jphysiol.1887.sp000252.
Jump up ^ Szent-Gyorgyi A (1945). "Studies on muscle". Acta Physiol Scandinav. 9 (Suppl): 25.
^ Jump up to: a b Straub FB, Feuer G (1989). "Adenosinetriphosphate. The functional group of actin. 1950". Biochimica et Biophysica Acta. 1000: 180–95. PMID 2673365. doi:10.1016/0006-3002(50)90052-7.
Jump up ^ Bárány M, Barron JT, Gu L, Bárány K (Dec 2001). "Exchange of the actin-bound nucleotide in intact arterial smooth muscle". The Journal of Biological Chemistry. 276 (51): 48398–403. PMID 11602582. doi:10.1074/jbc.M106227200 (inactive 2017-03-10).
^ Jump up to: a b c Elzinga M, Collins JH, Kuehl WM, Adelstein RS (Sep 1973). "Complete amino-acid sequence of actin of rabbit skeletal muscle". Proceedings of the National Academy of Sciences of the United States of America. 70 (9): 2687–91. PMC 427084  . PMID 4517681. doi:10.1073/pnas.70.9.2687.
^ Jump up to: a b Kabsch W, Mannherz HG, Suck D, Pai EF, Holmes KC (Sep 1990). "Atomic structure of the actin:DNase I complex". Nature. 347 (6288): 37–44. PMID 2395459. doi:10.1038/347037a0.
^ Jump up to: a b Holmes KC, Popp D, Gebhard W, Kabsch W (Sep 1990). "Atomic model of the actin filament". Nature. 347 (6288): 44–9. PMID 2395461. doi:10.1038/347044a0.
Jump up ^ Oriol C, Dubord C, Landon F (Jan 1977). "Crystallization of native striated-muscle actin". FEBS Letters. 73 (1): 89–91. PMID 320040. doi:10.1016/0014-5793(77)80022-7.
Jump up ^ Sawaya MR, Kudryashov DS, Pashkov I, Adisetiyo H, Reisler E, Yeates TO (Apr 2008). "Multiple crystal structures of actin dimers and their implications for interactions in the actin filament". Acta Crystallographica Section D. 64 (Pt 4): 454–65. PMC 2631129  . PMID 18391412. doi:10.1107/S0907444908003351.
Jump up ^ Narita A, Takeda S, Yamashita A, Maéda Y (Nov 2006). "Structural basis of actin filament capping at the barbed-end: a cryo-electron microscopy study". The EMBO Journal. 25 (23): 5626–33. PMC 1679762  . PMID 17110933. doi:10.1038/sj.emboj.7601395.
^ Jump up to: a b c d e f Oda T, Iwasa M, Aihara T, Maéda Y, Narita A (Jan 2009). "The nature of the globular- to fibrous-actin transition". Nature. 457 (7228): 441–5. PMID 19158791. doi:10.1038/nature07685.
^ Jump up to: a b c d von der Ecken J, Müller M, Lehman W, Manstein DJ, Penczek PA, Raunser S (May 2015). "Structure of the F-actin-tropomyosin complex". Nature. 519 (7541): 114–7. PMC 4477711  . PMID 25470062. doi:10.1038/nature14033.
Jump up ^ Hanukoglu I, Tanese N, Fuchs E (Feb 1983). "Complementary DNA sequence of a human cytoplasmic actin. Interspecies divergence of 3' non-coding regions". Journal of Molecular Biology. 163 (4): 673–8. PMID 6842590. doi:10.1016/0022-2836(83)90117-1.
^ Jump up to: a b c d Biología celular (in Spanish). Elsevier España. 2002. p. 132. ISBN 84-458-1105-3.
Jump up ^ Ponte P, Gunning P, Blau H, Kedes L (Oct 1983). "Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution". Molecular and Cellular Biology. 3 (10): 1783–91. PMC 370040  . PMID 6646124. doi:10.1128/MCB.3.10.1783.
^ Jump up to: a b c d Scott MP, Lodish HF, Berk A, Kaiser C, Krieger M, Bretscher A, Ploegh H, Amon A (2012). Molecular Cell Biology. San Francisco: W. H. Freeman. ISBN 1-4292-3413-X.
Jump up ^ Hara F, Yamashiro K, Nemoto N, Ohta Y, Yokobori S, Yasunaga T, Hisanaga S, Yamagishi A (Mar 2007). "An actin homolog of the archaeon Thermoplasma acidophilum that retains the ancient characteristics of eukaryotic actin". Journal of Bacteriology. 189 (5): 2039–45. PMC 1855749  . PMID 17189356. doi:10.1128/JB.01454-06.
^ Jump up to: a b Graceffa P, Dominguez R (Sep 2003). "Crystal structure of monomeric actin in the ATP state. Structural basis of nucleotide-dependent actin dynamics". The Journal of Biological Chemistry. 278 (36): 34172–80. PMID 12813032. doi:10.1074/jbc.M303689200.
Jump up ^ Reisler E (Feb 1993). "Actin molecular structure and function". Current Opinion in Cell Biology. 5 (1): 41–7. PMID 8448029. doi:10.1016/S0955-0674(05)80006-7.
Jump up ^ "cd00012: ACTIN". Conserved Domain Database. U.S. National Center for Biotechnology Information (NCBI).
^ Jump up to: a b Collins JH, Elzinga M (Aug 1975). "The primary structure of actin from rabbit skeletal muscle. Completion and analysis of the amino acid sequence". The Journal of Biological Chemistry. 250 (15): 5915–20. PMID 1150665.
^ Jump up to: a b c d e f g h Dos Remedios CG, Chhabra D (2008). Actin-binding Proteins and Disease. Springer. ISBN 0-387-71747-1.
Jump up ^ Rould MA, Wan Q, Joel PB, Lowey S, Trybus KM (Oct 2006). "Crystal structures of expressed non-polymerizable monomeric actin in the ADP and ATP states". The Journal of Biological Chemistry. 281 (42): 31909–19. PMID 16920713. doi:10.1074/jbc.M601973200.
^ Jump up to: a b Devlin TM (2006). Bioquimica. Barcelona: Reverté. ISBN 84-291-7208-4.
^ Jump up to: a b c Reisler E, Egelman EH (Dec 2007). "Actin structure and function: what we still do not understand". The Journal of Biological Chemistry. 282 (50): 36133–7. PMID 17965017. doi:10.1074/jbc.R700030200.
Jump up ^ Begg DA, Rodewald R, Rebhun LI (Dec 1978). "The visualization of actin filament polarity in thin sections. Evidence for the uniform polarity of membrane-associated filaments". The Journal of Cell Biology. 79 (3): 846–52. PMC 2110270  . PMID 569662. doi:10.1083/jcb.79.3.846.
Jump up ^ Geneser F (1981). Histologi. Munksgaard. p. 105. ISBN 87-16-08418-7.
^ Jump up to: a b c Hall JE, Guyton AC (2006). Textbook of medical physiology. St. Louis, Mo: Elsevier Saunders. p. 76. ISBN 0-7216-0240-1.
^ Jump up to: a b Simons CT, Staes A, Rommelaere H, Ampe C, Lewis SA, Cowan NJ (Feb 2004). "Selective contribution of eukaryotic prefoldin subunits to actin and tubulin binding". The Journal of Biological Chemistry. 279 (6): 4196–203. PMID 14634002. doi:10.1074/jbc.M306053200.
^ Jump up to: a b Martín-Benito J, Boskovic J, Gómez-Puertas P, Carrascosa JL, Simons CT, Lewis SA, Bartolini F, Cowan NJ, Valpuesta JM (Dec 2002). "Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT". The EMBO Journal. 21 (23): 6377–86. PMC 136944  . PMID 12456645. doi:10.1093/emboj/cdf640.
^ Jump up to: a b Vandamme D, Lambert E, Waterschoot D, Cognard C, Vandekerckhove J, Ampe C, Constantin B, Rommelaere H (Jul 2009). "alpha-Skeletal muscle actin nemaline myopathy mutants cause cell death in cultured muscle cells". Biochimica et Biophysica Acta. 1793 (7): 1259–71. PMID 19393268. doi:10.1016/j.bbamcr.2009.04.004.
^ Jump up to: a b Brackley KI, Grantham J (Jan 2009). "Activities of the chaperonin containing TCP-1 (CCT): implications for cell cycle progression and cytoskeletal organisation". Cell Stress & Chaperones. 14 (1): 23–31. PMC 2673901  . PMID 18595008. doi:10.1007/s12192-008-0057-x.
^ Jump up to: a b Stirling PC, Cuéllar J, Alfaro GA, El Khadali F, Beh CT, Valpuesta JM, Melki R, Leroux MR (Mar 2006). "PhLP3 modulates CCT-mediated actin and tubulin folding via ternary complexes with substrates". The Journal of Biological Chemistry. 281 (11): 7012–21. PMID 16415341. doi:10.1074/jbc.M513235200.
Jump up ^ Hansen WJ, Cowan NJ, Welch WJ (Apr 1999). "Prefoldin-nascent chain complexes in the folding of cytoskeletal proteins". The Journal of Cell Biology. 145 (2): 265–77. PMC 2133115  . PMID 10209023. doi:10.1083/jcb.145.2.265.
Jump up ^ Martín-Benito J, Grantham J, Boskovic J, Brackley KI, Carrascosa JL, Willison KR, Valpuesta JM (Mar 2007). "The inter-ring arrangement of the cytosolic chaperonin CCT". EMBO Reports. 8 (3): 252–7. PMC 1808031  . PMID 17304242. doi:10.1038/sj.embor.7400894.
Jump up ^ Neirynck K, Waterschoot D, Vandekerckhove J, Ampe C, Rommelaere H (Jan 2006). "Actin interacts with CCT via discrete binding sites: a binding transition-release model for CCT-mediated actin folding". Journal of Molecular Biology. 355 (1): 124–38. PMID 16300788. doi:10.1016/j.jmb.2005.10.051.
^ Jump up to: a b c Vavylonis D, Yang Q, O'Shaughnessy B (Jun 2005). "Actin polymerization kinetics, cap structure, and fluctuations". Proceedings of the National Academy of Sciences of the United States of America. 102 (24): 8543–8. PMC 1150824  . PMID 15939882. doi:10.1073/pnas.0501435102.
Jump up ^ Vandekerckhove J, Weber K (Dec 1978). "At least six different actins are expressed in a higher mammal: an analysis based on the amino acid sequence of the amino-terminal tryptic peptide". Journal of Molecular Biology. 126 (4): 783–802. PMID 745245. doi:10.1016/0022-2836(78)90020-7.
Jump up ^ Khaitlina SY (2001). "Functional specificity of actin isoforms". International Review of Cytology. International Review of Cytology. 202: 35–98. ISBN 9780123646064. PMID 11061563. doi:10.1016/S0074-7696(01)02003-4.
Jump up ^ Garner EC, Campbell CS, Weibel DB, Mullins RD (Mar 2007). "Reconstitution of DNA segregation driven by assembly of a prokaryotic actin homolog". Science. 315 (5816): 1270–4. PMC 2851738  . PMID 17332412. doi:10.1126/science.1138527.
Jump up ^ Kawamura M, Maruyama K (Mar 1970). "Electron microscopic particle length of F-actin polymerized in vitro". Journal of Biochemistry. 67 (3): 437–57. PMID 5463781.
Jump up ^ Hausman RE, Cooper GM (2007). "Chapter 12: The Cytoskeleton and Cell Movement". The cell: a molecular approach. Washington, DC :, Sunderland, MA: ASM Press, Sinauer Associates. ISBN 0-87893-219-4.
Jump up ^ Bindschadler M, Osborn EA, Dewey CF, McGrath JL (May 2004). "A mechanistic model of the actin cycle". Biophysical Journal. 86 (5): 2720–39. PMC 1304143  . PMID 15111391. doi:10.1016/S0006-3495(04)74326-X.
Jump up ^ Kirschner MW (Jul 1980). "Implications of treadmilling for the stability and polarity of actin and tubulin polymers in vivo". The Journal of Cell Biology. 86 (1): 330–4. PMC 2110666  . PMID 6893454. doi:10.1083/jcb.86.1.330.
Jump up ^ Ghodsi H, Kazemi MT (June 2011). "Elastic Properties of Actin Assemblies in Different States of Nucleotide Binding". Cell. Mol. Bioeng. 5 (1): 1–13. doi:10.1007/s12195-011-0181-z.
Jump up ^ Plopper G, Lewin B, Cassimeris L (2007). Cells. Boston: Jones and Bartlett Publishers. ISBN 0-7637-3905-7.
Jump up ^ Zhang DS, Piazza V, Perrin BJ, Rzadzinska AK, Poczatek JC, Wang M, Prosser HM, Ervasti JM, Corey DP, Lechene CP (Jan 2012). "Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia". Nature. 481 (7382): 520–4. PMC 3267870  . PMID 22246323. doi:10.1038/nature10745.
Jump up ^ PDB: 2BTF; Schutt CE, Myslik JC, Rozycki MD, Goonesekere NC, Lindberg U (Oct 1993). "The structure of crystalline profilin-beta-actin". Nature. 365 (6449): 810–6. PMID 8413665. doi:10.1038/365810a0.
Jump up ^ Dominguez R (Nov 2004). "Actin-binding proteins--a unifying hypothesis". Trends in Biochemical Sciences. 29 (11): 572–8. PMID 15501675. doi:10.1016/j.tibs.2004.09.004.
Jump up ^ Goldschmidt-Clermont PJ, Furman MI, Wachsstock D, Safer D, Nachmias VT, Pollard TD (Sep 1992). "The control of actin nucleotide exchange by thymosin beta 4 and profilin. A potential regulatory mechanism for actin polymerization in cells". Molecular Biology of the Cell. 3 (9): 1015–24. PMC 275662  . PMID 1330091. doi:10.1091/mbc.3.9.1015.
Jump up ^ Witke W, Podtelejnikov AV, Di Nardo A, Sutherland JD, Gurniak CB, Dotti C, Mann M (Feb 1998). "In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly". The EMBO Journal. 17 (4): 967–76. PMC 1170446  . PMID 9463375. doi:10.1093/emboj/17.4.967.
Jump up ^ Carlsson L, Nyström LE, Sundkvist I, Markey F, Lindberg U (Sep 1977). "Actin polymerizability is influenced by profilin, a low molecular weight protein in non-muscle cells". Journal of Molecular Biology. 115 (3): 465–83. PMID 563468. doi:10.1016/0022-2836(77)90166-8.
Jump up ^ Kiselar JG, Janmey PA, Almo SC, Chance MR (Apr 2003). "Visualizing the Ca2+-dependent activation of gelsolin by using synchrotron footprinting". Proceedings of the National Academy of Sciences of the United States of America. 100 (7): 3942–7. PMC 153027  . PMID 12655044. doi:10.1073/pnas.0736004100.
Jump up ^ Ghoshdastider U, Popp D, Burtnick LD, Robinson RC (Nov 2013). "The expanding superfamily of gelsolin homology domain proteins". Cytoskeleton. 70 (11): 775–95. PMID 24155256. doi:10.1002/cm.21149.
Jump up ^ Southwick FS (Jun 2000). "Gelsolin and ADF/cofilin enhance the actin dynamics of motile cells". Proceedings of the National Academy of Sciences of the United States of America. 97 (13): 6936–8. PMC 34364  . PMID 10860951. doi:10.1073/pnas.97.13.6936.
Jump up ^ Caldwell JE, Heiss SG, Mermall V, Cooper JA (Oct 1989). "Effects of CapZ, an actin capping protein of muscle, on the polymerization of actin". Biochemistry. 28 (21): 8506–14. PMID 2557904. doi:10.1021/bi00447a036.
Jump up ^ Weber A, Pennise CR, Babcock GG, Fowler VM (Dec 1994). "Tropomodulin caps the pointed ends of actin filaments". The Journal of Cell Biology. 127 (6 Pt 1): 1627–35. PMC 2120308  . PMID 7798317. doi:10.1083/jcb.127.6.1627.
Jump up ^ Robinson RC, Turbedsky K, Kaiser DA, Marchand JB, Higgs HN, Choe S, Pollard TD (Nov 2001). "Crystal structure of Arp2/3 complex". Science. 294 (5547): 1679–84. PMID 11721045. doi:10.1126/science.1066333.
Jump up ^ Mullins RD, Pollard TD (Apr 1999). "Structure and function of the Arp2/3 complex". Current Opinion in Structural Biology. 9 (2): 244–9. PMID 10322212. doi:10.1016/S0959-440X(99)80034-7.
Jump up ^ Machesky LM, Gould KL (Feb 1999). "The Arp2/3 complex: a multifunctional actin organizer". Current Opinion in Cell Biology. 11 (1): 117–21. PMID 10047519. doi:10.1016/S0955-0674(99)80014-3.
Jump up ^ Morton WM, Ayscough KR, McLaughlin PJ (Jun 2000). "Latrunculin alters the actin-monomer subunit interface to prevent polymerization". Nature Cell Biology. 2 (6): 376–8. PMID 10854330. doi:10.1038/35014075.
^ Jump up to: a b Cooper JA (Oct 1987). "Effects of cytochalasin and phalloidin on actin". The Journal of Cell Biology. 105 (4): 1473–8. PMC 2114638  . PMID 3312229. doi:10.1083/jcb.105.4.1473.
Jump up ^ Rubtsova SN, Kondratov RV, Kopnin PB, Chumakov PM, Kopnin BP, Vasiliev JM (Jul 1998). "Disruption of actin microfilaments by cytochalasin D leads to activation of p53". FEBS Letters. 430 (3): 353–7. PMID 9688570. doi:10.1016/S0014-5793(98)00692-9.
Jump up ^ Huber F, Schnauß J, Rönicke S, Rauch P, Müller K, Fütterer C, Käs J (Jan 2013). "Emergent complexity of the cytoskeleton: from single filaments to tissue". Advances in Physics. 62 (1): 1–112. PMC 3985726  . PMID 24748680. doi:10.1080/00018732.2013.771509. online
^ Jump up to: a b c Grummt I (Apr 2006). "Actin and myosin as transcription factors". Current Opinion in Genetics & Development. 16 (2): 191–6. PMID 16495046. doi:10.1016/j.gde.2006.02.001.
Jump up ^ Zouwail S, Pettitt TR, Dove SK, Chibalina MV, Powner DJ, Haynes L, Wakelam MJ, Insall RH (Jul 2005). "Phospholipase D activity is essential for actin localization and actin-based motility in Dictyostelium". The Biochemical Journal. 389 (Pt 1): 207–14. PMC 1184553  . PMID 15769249. doi:10.1042/BJ20050085.
^ Jump up to: a b Eckert R, Randall D, Burggren WW, French K (2002). Eckert animal physiology: mechanisms and adaptations. New York: W.H. Freeman and CO. ISBN 0-7167-3863-5.
Jump up ^ Trombocitopenias (Spanish Edition) (2nd ed.). Elsevier Espana. 2001. p. 25. ISBN 84-8174-595-2.
^ Jump up to: a b c Paniagua R, Nistal M, Sesma P, Álvarez-Uría M, Fraile B, Anadón R, José Sáez F (2002). Citología e histología vegetal y animal (in Spanish). McGraw-Hill Interamericana de España, S.A.U. ISBN 84-486-0436-9.
Jump up ^ Xu K, Zhong G, Zhuang X (Jan 2013). "Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons". Science. 339 (6118): 452–6. PMC 3815867  . PMID 23239625. doi:10.1126/science.1232251.
^ Jump up to: a b Moseley JB, Goode BL (Sep 2006). "The yeast actin cytoskeleton: from cellular function to biochemical mechanism". Microbiology and Molecular Biology Reviews. 70 (3): 605–45. PMC 1594590  . PMID 16959963. doi:10.1128/MMBR.00013-06.
Jump up ^ Meagher RB, McKinney EC, Kandasamy MK (Jun 1999). "Isovariant dynamics expand and buffer the responses of complex systems: the diverse plant actin gene family". The Plant Cell. 11 (6): 995–1006. PMC 1464670  . PMID 10368172. doi:10.1105/tpc.11.6.995.
Jump up ^ PDB 1unc; Vermeulen W, Vanhaesebrouck P, Van Troys M, Verschueren M, Fant F, Goethals M, Ampe C, Martins JC, Borremans FA (May 2004). "Solution structures of the C-terminal headpiece subdomains of human villin and advillin, evaluation of headpiece F-actin-binding requirements". Protein Science. 13 (5): 1276–87. PMC 2286768  . PMID 15096633. doi:10.1110/ps.03518104.
^ Jump up to: a b Higaki T, Sano T, Hasezawa S (Dec 2007). "Actin microfilament dynamics and actin side-binding proteins in plants". Current Opinion in Plant Biology. 10 (6): 549–56. PMID 17936064. doi:10.1016/j.pbi.2007.08.012.
Jump up ^ Kovar DR, Staiger CJ, Weaver EA, McCurdy DW (Dec 2000). "AtFim1 is an actin filament crosslinking protein from Arabidopsis thaliana". The Plant Journal. 24 (5): 625–36. PMID 11123801. doi:10.1046/j.1365-313x.2000.00907.x.
^ Jump up to: a b Clark TG, Merriam RW (Dec 1977). "Diffusible and bound actin nuclei of Xenopus laevis oocytes". Cell. 12 (4): 883–91. PMID 563771. doi:10.1016/0092-8674(77)90152-0.
Jump up ^ Hofmann WA (2009-01-01). "Cell and molecular biology of nuclear actin". International Review of Cell and Molecular Biology. International Review of Cell and Molecular Biology. 273: 219–63. ISBN 9780123748041. PMID 19215906. doi:10.1016/S1937-6448(08)01806-6.
^ Jump up to: a b Bohnsack MT, Stüven T, Kuhn C, Cordes VC, Görlich D (Mar 2006). "A selective block of nuclear actin export stabilizes the giant nuclei of Xenopus oocytes". Nature Cell Biology. 8 (3): 257–63. PMID 16489345. doi:10.1038/ncb1357.
Jump up ^ Dopie J, Skarp KP, Rajakylä EK, Tanhuanpää K, Vartiainen MK (Feb 2012). "Active maintenance of nuclear actin by importin 9 supports transcription". Proceedings of the National Academy of Sciences of the United States of America. 109 (9): E544–52. PMC 3295300  . PMID 22323606. doi:10.1073/pnas.1118880109.
Jump up ^ Wada A, Fukuda M, Mishima M, Nishida E (Mar 1998). "Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein". The EMBO Journal. 17 (6): 1635–41. PMC 1170511  . PMID 9501085. doi:10.1093/emboj/17.6.1635.
Jump up ^ Stüven T, Hartmann E, Görlich D (Nov 2003). "Exportin 6: a novel nuclear export receptor that is specific for profilin.actin complexes". The EMBO Journal. 22 (21): 5928–40. PMC 275422  . PMID 14592989. doi:10.1093/emboj/cdg565.
^ Jump up to: a b Hofmann WA, Arduini A, Nicol SM, Camacho CJ, Lessard JL, Fuller-Pace FV, de Lanerolle P (Jul 2009). "SUMOylation of nuclear actin". The Journal of Cell Biology. 186 (2): 193–200. PMC 2717643  . PMID 19635839. doi:10.1083/jcb.200905016.
^ Jump up to: a b Chhabra D, dos Remedios CG (Sep 2005). "Cofilin, actin and their complex observed in vivo using fluorescence resonance energy transfer". Biophysical Journal. 89 (3): 1902–8. PMC 1366693  . PMID 15994898. doi:10.1529/biophysj.105.062083.
Jump up ^ McDonald D, Carrero G, Andrin C, de Vries G, Hendzel MJ (Feb 2006). "Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations". The Journal of Cell Biology. 172 (4): 541–52. PMC 2063674  . PMID 16476775. doi:10.1083/jcb.200507101.
Jump up ^ Jockusch BM, Schoenenberger CA, Stetefeld J, Aebi U (Aug 2006). "Tracking down the different forms of nuclear actin". Trends in Cell Biology. 16 (8): 391–6. PMID 16828286. doi:10.1016/j.tcb.2006.06.006.
^ Jump up to: a b c d Migocka-Patrzałek M, Makowiecka A, Nowak D, Mazur AJ, Hofmann WA, Malicka-Błaszkiewicz M (Nov 2015). "β- and γ-Actins in the nucleus of human melanoma A375 cells". Histochemistry and Cell Biology. 144 (5): 417–28. PMC 4628621  . PMID 26239425. doi:10.1007/s00418-015-1349-8.
Jump up ^ Pederson T, Aebi U (2002-12-01). "Actin in the nucleus: what form and what for?". Journal of Structural Biology. 140 (1–3): 3–9. PMID 12490148. doi:10.1016/s1047-8477(02)00528-2.
Jump up ^ Bergeron SE, Zhu M, Thiem SM, Friderici KH, Rubenstein PA (May 2010). "Ion-dependent polymerization differences between mammalian beta- and gamma-nonmuscle actin isoforms". The Journal of Biological Chemistry. 285 (21): 16087–95. PMC 2871477  . PMID 20308063. doi:10.1074/jbc.M110.110130.
Jump up ^ Spencer VA (Sep 2011). "Nuclear actin: A key player in extracellular matrix-nucleus communication". Communicative & Integrative Biology. 4 (5): 511–2. PMC 3204115  . PMID 22046450. doi:10.4161/cib.4.5.16256 (inactive 2017-03-10).
^ Jump up to: a b Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, Crabtree GR (Nov 1998). "Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling". Cell. 95 (5): 625–36. PMID 9845365. doi:10.1016/s0092-8674(00)81633-5.
^ Jump up to: a b Hofmann WA, Stojiljkovic L, Fuchsova B, Vargas GM, Mavrommatis E, Philimonenko V, Kysela K, Goodrich JA, Lessard JL, Hope TJ, Hozak P, de Lanerolle P (Nov 2004). "Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II". Nature Cell Biology. 6 (11): 1094–101. PMID 15502823. doi:10.1038/ncb1182.
^ Jump up to: a b Hu P, Wu S, Hernandez N (Dec 2004). "A role for beta-actin in RNA polymerase III transcription". Genes & Development. 18 (24): 3010–5. PMC 535912  . PMID 15574586. doi:10.1101/gad.1250804.
^ Jump up to: a b Philimonenko VV, Zhao J, Iben S, Dingová H, Kyselá K, Kahle M, Zentgraf H, Hofmann WA, de Lanerolle P, Hozák P, Grummt I (Dec 2004). "Nuclear actin and myosin I are required for RNA polymerase I transcription". Nature Cell Biology. 6 (12): 1165–72. PMID 15558034. doi:10.1038/ncb1190.
Jump up ^ Maraldi NM, Lattanzi G, Marmiroli S, Squarzoni S, Manzoli FA (2004-01-01). "New roles for lamins, nuclear envelope proteins and actin in the nucleus". Advances in Enzyme Regulation. 44: 155–72. PMID 15581488. doi:10.1016/j.advenzreg.2003.11.005.
Jump up ^ Tondeleir D, Lambrechts A, Müller M, Jonckheere V, Doll T, Vandamme D, Bakkali K, Waterschoot D, Lemaistre M, Debeir O, Decaestecker C, Hinz B, Staes A, Timmerman E, Colaert N, Gevaert K, Vandekerckhove J, Ampe C (Aug 2012). "Cells lacking β-actin are genetically reprogrammed and maintain conditional migratory capacity". Molecular & Cellular Proteomics. 11 (8): 255–71. PMC 3412960  . PMID 22448045. doi:10.1074/mcp.M111.015099.
Jump up ^ Holaska JM, Kowalski AK, Wilson KL (Sep 2004). "Emerin caps the pointed end of actin filaments: evidence for an actin cortical network at the nuclear inner membrane". PLoS Biology. 2 (9): E231. PMC 509406  . PMID 15328537. doi:10.1371/journal.pbio.0020231.
Jump up ^ Puckelwartz M, McNally EM (2011-01-01). "Emery–Dreifuss muscular dystrophy". Handbook of Clinical Neurology. Handbook of Clinical Neurology. 101: 155–66. ISBN 9780080450315. PMID 21496632. doi:10.1016/B978-0-08-045031-5.00012-8.
Jump up ^ Farrants AK (Jun 2008). "Chromatin remodelling and actin organisation". FEBS Letters. 582 (14): 2041–50. PMID 18442483. doi:10.1016/j.febslet.2008.04.032.
Jump up ^ Sjölinder M, Björk P, Söderberg E, Sabri N, Farrants AK, Visa N (Aug 2005). "The growing pre-mRNA recruits actin and chromatin-modifying factors to transcriptionally active genes". Genes & Development. 19 (16): 1871–84. PMC 1186187  . PMID 16103215. doi:10.1101/gad.339405.
^ Jump up to: a b Percipalle P, Visa N (Mar 2006). "Molecular functions of nuclear actin in transcription". The Journal of Cell Biology. 172 (7): 967–71. PMC 2063754  . PMID 16549500. doi:10.1083/jcb.200512083.
Jump up ^ Fedorova E, Zink D (Nov 2008). "Nuclear architecture and gene regulation". Biochimica et Biophysica Acta. 1783 (11): 2174–84. PMID 18718493. doi:10.1016/j.bbamcr.2008.07.018.
Jump up ^ Skarp KP, Vartiainen MK (Aug 2010). "Actin on DNA-an ancient and dynamic relationship". Cytoskeleton. 67 (8): 487–95. PMID 20593452. doi:10.1002/cm.20464.
Jump up ^ Olave IA, Reck-Peterson SL, Crabtree GR (2002-01-01). "Nuclear actin and actin-related proteins in chromatin remodeling". Annual Review of Biochemistry. 71: 755–81. PMID 12045110. doi:10.1146/annurev.biochem.71.110601.135507.
Jump up ^ Zheng B, Han M, Bernier M, Wen JK (May 2009). "Nuclear actin and actin-binding proteins in the regulation of transcription and gene expression". The FEBS Journal. 276 (10): 2669–85. PMC 2978034  . PMID 19459931. doi:10.1111/j.1742-4658.2009.06986.x.
Jump up ^ Ferrai C, Naum-Onganía G, Longobardi E, Palazzolo M, Disanza A, Diaz VM, Crippa MP, Scita G, Blasi F (Aug 2009). "Induction of HoxB transcription by retinoic acid requires actin polymerization". Molecular Biology of the Cell. 20 (15): 3543–51. PMC 2719572  . PMID 19477923. doi:10.1091/mbc.E09-02-0114.
Jump up ^ Xu YZ, Thuraisingam T, Morais DA, Rola-Pleszczynski M, Radzioch D (Mar 2010). "Nuclear translocation of beta-actin is involved in transcriptional regulation during macrophage differentiation of HL-60 cells". Molecular Biology of the Cell. 21 (5): 811–20. PMC 2828967  . PMID 20053683. doi:10.1091/mbc.E09-06-0534.
^ Jump up to: a b Miyamoto K, Pasque V, Jullien J, Gurdon JB (May 2011). "Nuclear actin polymerization is required for transcriptional reprogramming of Oct4 by oocytes". Genes & Development. 25 (9): 946–58. PMC 3084028  . PMID 21536734. doi:10.1101/gad.615211.
Jump up ^ Huang W, Ghisletti S, Saijo K, Gandhi M, Aouadi M, Tesz GJ, Zhang DX, Yao J, Czech MP, Goode BL, Rosenfeld MG, Glass CK (Feb 2011). "Coronin 2A mediates actin-dependent de-repression of inflammatory response genes". Nature. 470 (7334): 414–8. PMC 3464905  . PMID 21331046. doi:10.1038/nature09703.
Jump up ^ Miyamoto K, Gurdon JB (Sep 2011). "Nuclear actin and transcriptional activation". Communicative & Integrative Biology. 4 (5): 582–3. PMC 3204135  . PMID 22046469. doi:10.4161/cib.4.5.16491 (inactive 2017-03-10).
Jump up ^ Chuang CH, Carpenter AE, Fuchsova B, Johnson T, de Lanerolle P, Belmont AS (Apr 2006). "Long-range directional movement of an interphase chromosome site". Current Biology. 16 (8): 825–31. PMID 16631592. doi:10.1016/j.cub.2006.03.059.
Jump up ^ Hofmann WA, Vargas GM, Ramchandran R, Stojiljkovic L, Goodrich JA, de Lanerolle P (Nov 2006). "Nuclear myosin I is necessary for the formation of the first phosphodiester bond during transcription initiation by RNA polymerase II". Journal of Cellular Biochemistry. 99 (4): 1001–9. PMID 16960872. doi:10.1002/jcb.21035.
Jump up ^ Olson EN, Nordheim A (May 2010). "Linking actin dynamics and gene transcription to drive cellular motile functions". Nature Reviews Molecular Cell Biology. 11 (5): 353–65. PMC 3073350  . PMID 20414257. doi:10.1038/nrm2890.
Jump up ^ Miralles F, Posern G, Zaromytidou AI, Treisman R (May 2003). "Actin dynamics control SRF activity by regulation of its coactivator MAL". Cell. 113 (3): 329–42. PMID 12732141. doi:10.1016/s0092-8674(03)00278-2.
Jump up ^ Vartiainen MK (Jun 2008). "Nuclear actin dynamics--from form to function". FEBS Letters. 582 (14): 2033–40. PMID 18423404. doi:10.1016/j.febslet.2008.04.010.
Jump up ^ Knöll B (Jun 2010). "Actin-mediated gene expression in neurons: the MRTF-SRF connection". Biological Chemistry. 391 (6): 591–7. PMID 20370316. doi:10.1515/BC.2010.061.
^ Jump up to: a b Cooper, Geoffrey M. (2000-01-01). "Actin, Myosin, and Cell Movement".
Jump up ^ de Luna AB, Staff VV, López-Sendón J, Attie F, Ezquerra EA (2003). Cardiología clínica. Elsevier España. ISBN 84-458-1179-7.
^ Jump up to: a b Dominiczak MH, Baynes J (2005). Bioquimica Medica: con acceso a Student Consult (Spanish Edition). Elsevier Espana. ISBN 84-8174-866-8.
Jump up ^ Fujiwara K, Porter ME, Pollard TD (Oct 1978). "Alpha-actinin localization in the cleavage furrow during cytokinesis". The Journal of Cell Biology. 79 (1): 268–75. PMC 2110217  . PMID 359574. doi:10.1083/jcb.79.1.268.
Jump up ^ Pelham RJ, Chang F (Sep 2002). "Actin dynamics in the contractile ring during cytokinesis in fission yeast". Nature. 419 (6902): 82–6. PMID 12214236. doi:10.1038/nature00999.
Jump up ^ Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, Tsuruo T (Mar 1997). "Actin cleavage by CPP-32/apopain during the development of apoptosis". Oncogene. 14 (9): 1007–12. PMID 9070648. doi:10.1038/sj.onc.1200919.
Jump up ^ Wang KK (Jan 2000). "Calpain and caspase: can you tell the difference?". Trends in Neurosciences. 23 (1): 20–6. PMID 10631785. doi:10.1016/S0166-2236(99)01479-4.
Jump up ^ Villa PG, Henzel WJ, Sensenbrenner M, Henderson CE, Pettmann B (Mar 1998). "Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis". Journal of Cell Science. 111 (Pt 6): 713–22. PMID 9472000.
Jump up ^ Huot J, Houle F, Rousseau S, Deschesnes RG, Shah GM, Landry J (Nov 1998). "SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis". The Journal of Cell Biology. 143 (5): 1361–73. PMC 2133090  . PMID 9832563. doi:10.1083/jcb.143.5.1361.
Jump up ^ Adams CL, Nelson WJ, Smith SJ (Dec 1996). "Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion". The Journal of Cell Biology. 135 (6 Pt 2): 1899–911. PMC 2133977  . PMID 8991100. doi:10.1083/jcb.135.6.1899.
Jump up ^ Witke W, Schleicher M, Noegel AA (Jan 1992). "Redundancy in the microfilament system: abnormal development of Dictyostelium cells lacking two F-actin cross-linking proteins". Cell. 68 (1): 53–62. PMID 1732064. doi:10.1016/0092-8674(92)90205-Q.
Jump up ^ Fernandez-Valle C, Gorman D, Gomez AM, Bunge MB (Jan 1997). "Actin plays a role in both changes in cell shape and gene-expression associated with Schwann cell myelination". The Journal of Neuroscience. 17 (1): 241–50. PMID 8987752.
Jump up ^ Wolyniak MJ, Sundstrom P (Oct 2007). "Role of actin cytoskeletal dynamics in activation of the cyclic AMP pathway and HWP1 gene expression in Candida albicans". Eukaryotic Cell. 6 (10): 1824–40. PMC 2043390  . PMID 17715368. doi:10.1128/EC.00188-07.
Jump up ^ Tanaka H, Iguchi N, Egydio de Carvalho C, Tadokoro Y, Yomogida K, Nishimune Y (Aug 2003). "Novel actin-like proteins T-ACTIN 1 and T-ACTIN 2 are differentially expressed in the cytoplasm and nucleus of mouse haploid germ cells". Biology of Reproduction. 69 (2): 475–82. PMID 12672658. doi:10.1095/biolreprod.103.015867.
Jump up ^ Jiang YW, Stillman DJ (Mar 1996). "Epigenetic effects on yeast transcription caused by mutations in an actin-related protein present in the nucleus". Genes & Development. 10 (5): 604–19. PMID 8598290. doi:10.1101/gad.10.5.604.
Jump up ^ Manor U, Kachar B (Dec 2008). "Dynamic length regulation of sensory stereocilia". Seminars in Cell & Developmental Biology. 19 (6): 502–10. PMC 2650238  . PMID 18692583. doi:10.1016/j.semcdb.2008.07.006.
Jump up ^ Rzadzinska AK, Schneider ME, Davies C, Riordan GP, Kachar B (Mar 2004). "An actin molecular treadmill and myosins maintain stereocilia functional architecture and self-renewal". The Journal of Cell Biology. 164 (6): 887–97. PMC 2172292  . PMID 15024034. doi:10.1083/jcb.200310055.
Jump up ^ Xu J, Van Keymeulen A, Wakida NM, Carlton P, Berns MW, Bourne HR (May 2007). "Polarity reveals intrinsic cell chirality". Proceedings of the National Academy of Sciences of the United States of America. 104 (22): 9296–300. PMC 1890488  . PMID 17517645. doi:10.1073/pnas.0703153104.
Jump up ^ Tamada A, Kawase S, Murakami F, Kamiguchi H (Feb 2010). "Autonomous right-screw rotation of growth cone filopodia drives neurite turning". The Journal of Cell Biology. 188 (3): 429–41. PMC 2819689  . PMID 20123994. doi:10.1083/jcb.200906043.
Jump up ^ Wan LQ, Ronaldson K, Park M, Taylor G, Zhang Y, Gimble JM, Vunjak-Novakovic G (Jul 2011). "Micropatterned mammalian cells exhibit phenotype-specific left-right asymmetry". Proceedings of the National Academy of Sciences of the United States of America. 108 (30): 12295–300. PMC 3145729  . PMID 21709270. doi:10.1073/pnas.1103834108.
Jump up ^ Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB (Apr 2004). "A gene atlas of the mouse and human protein-encoding transcriptomes". Proceedings of the National Academy of Sciences of the United States of America. 101 (16): 6062–7. PMC 395923  . PMID 15075390. doi:10.1073/pnas.0400782101.
^ Jump up to: a b "ACTS_HUMAN". P68133. UniProt Consortium. Retrieved 2013-01-21.
^ Jump up to: a b Bathe FS, Rommelaere H, Machesky LM (2007). "Phenotypes of myopathy-related actin mutants in differentiated C2C12 myotubes". BMC Cell Biology. 8 (1): 2. PMC 1779783  . PMID 17227580. doi:10.1186/1471-2121-8-2.
Jump up ^ Kaindl AM, Rüschendorf F, Krause S, Goebel HH, Koehler K, Becker C, Pongratz D, Müller-Höcker J, Nürnberg P, Stoltenburg-Didinger G, Lochmüller H, Huebner A (Nov 2004). "Missense mutations of ACTA1 cause dominant congenital myopathy with cores". Journal of Medical Genetics. 41 (11): 842–8. PMC 1735626  . PMID 15520409. doi:10.1136/jmg.2004.020271.
Jump up ^ Sparrow JC, Nowak KJ, Durling HJ, Beggs AH, Wallgren-Pettersson C, Romero N, Nonaka I, Laing NG (Sep 2003). "Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1)". Neuromuscular Disorders. 13 (7–8): 519–31. PMID 12921789. doi:10.1016/S0960-8966(03)00101-9.
Jump up ^ North K, Ryan MM (2002). "Nemaline Myopathy". In Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle.
Jump up ^ Ilkovski B, Nowak KJ, Domazetovska A, Maxwell AL, Clement S, Davies KE, Laing NG, North KN, Cooper ST (Aug 2004). "Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms". Human Molecular Genetics. 13 (16): 1727–43. PMID 15198992. doi:10.1093/hmg/ddh185.
Jump up ^ Clarke NF, Ilkovski B, Cooper S, Valova VA, Robinson PJ, Nonaka I, Feng JJ, Marston S, North K (Jun 2007). "The pathogenesis of ACTA1-related congenital fiber type disproportion". Annals of Neurology. 61 (6): 552–61. PMID 17387733. doi:10.1002/ana.21112.
^ Jump up to: a b Miwa T, Manabe Y, Kurokawa K, Kamada S, Kanda N, Bruns G, Ueyama H, Kakunaga T (Jun 1991). "Structure, chromosome location, and expression of the human smooth muscle (enteric type) gamma-actin gene: evolution of six human actin genes". Molecular and Cellular Biology. 11 (6): 3296–306. PMC 360182  . PMID 1710027. doi:10.1128/mcb.11.6.3296.
Jump up ^ Watson MB, Lind MJ, Smith L, Drew PJ, Cawkwell L (2007). "Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model". Acta Oncologica. 46 (5): 651–8. PMID 17562441. doi:10.1080/02841860601156157.
Jump up ^ Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, Amor D, Ades L, McConnell V, Willoughby CE, Abuelo D, Willing M, Lewis RA, Kim DH, Scherer S, Tung PP, Ahn C, Buja LM, Raman CS, Shete SS, Milewicz DM (Dec 2007). "Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections". Nature Genetics. 39 (12): 1488–93. PMID 17994018. doi:10.1038/ng.2007.6.
Jump up ^ Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS, Estrera AL, Safi HJ, Veeraraghavan S, Muzny DM, Wheeler DA, Willerson JT, Yu RK, Shete SS, Scherer SE, Raman CS, Buja LM, Milewicz DM (May 2009). "Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease". American Journal of Human Genetics. 84 (5): 617–27. PMC 2680995  . PMID 19409525. doi:10.1016/j.ajhg.2009.04.007.
Jump up ^ Akpolat N, Yahsi S, Godekmerdan A, Yalniz M, Demirbag K (Sep 2005). "The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study". Histopathology. 47 (3): 276–80. PMID 16115228. doi:10.1111/j.1365-2559.2005.02226.x.
Jump up ^ Hamada H, Petrino MG, Kakunaga T (Oct 1982). "Molecular structure and evolutionary origin of human cardiac muscle actin gene". Proceedings of the National Academy of Sciences of the United States of America. 79 (19): 5901–5. PMC 347018  . PMID 6310553. doi:10.1073/pnas.79.19.5901.
^ Jump up to: a b Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT (May 1998). "Actin mutations in dilated cardiomyopathy, a heritable form of heart failure". Science. 280 (5364): 750–2. PMID 9563954. doi:10.1126/science.280.5364.750.
Jump up ^ Xia XG, Zhou H, Samper E, Melov S, Xu Z (Jan 2006). "Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice". PLoS Genetics. 2 (1): e10. PMC 1358942  . PMID 16450009. doi:10.1371/journal.pgen.0020010.
Jump up ^ Online Mendelian Inheritance in Man (OMIM) Actin, alpha, cardiac muscle; ACTC1 -102540
Jump up ^ Matsson H, Eason J, Bookwalter CS, Klar J, Gustavsson P, Sunnegårdh J, Enell H, Jonzon A, Vikkula M, Gutierrez I, Granados-Riveron J, Pope M, Bu'Lock F, Cox J, Robinson TE, Song F, Brook DJ, Marston S, Trybus KM, Dahl N (Jan 2008). "Alpha-cardiac actin mutations produce atrial septal defects". Human Molecular Genetics. 17 (2): 256–65. PMID 17947298. doi:10.1093/hmg/ddm302.
Jump up ^ Kabaeva Z (2002). Genetic analysis in hypertrophic cardiomyopathy: missense mutations in the ventricular myosin regulatory light chain gene (Doctor medicinae). Humboldt-Universität zu Berlin. Retrieved 2013-01-21.
Jump up ^ Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L (Sep 2000). "Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy". Journal of Molecular and Cellular Cardiology. 32 (9): 1687–94. PMID 10966831. doi:10.1006/jmcc.2000.1204.
Jump up ^ Ramírez CD, Ramírez RP (March 2004). "Cardiomiopatía hipertrófica familiar: Genes, mutaciones y modelos animales. Revisión". Invest. Clín (in Spanish). 45 (1): 69–100.
Jump up ^ Kaski JP, Syrris P, Burch M, Tomé-Esteban MT, Fenton M, Christiansen M, Andersen PS, Sebire N, Ashworth M, Deanfield JE, McKenna WJ, Elliott PM (Nov 2008). "Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes". Heart. 94 (11): 1478–84. PMID 18467357. doi:10.1136/hrt.2007.134684.
Jump up ^ Pigott TJ, Jefferson D (1991). "Idiopathic common peroneal nerve palsy--a review of thirteen cases". British Journal of Neurosurgery. 5 (1): 7–11. PMID 1850600. doi:10.3109/02688699108998440.
Jump up ^ "Gene: ACTB". AceView. U.S. National Center for Biotechnology Information (NCBI). Retrieved 2013-01-21.
Jump up ^ Chang KW, Yang PY, Lai HY, Yeh TS, Chen TC, Yeh CT (Sep 2006). "Identification of a novel actin isoform in hepatocellular carcinoma". Hepatology Research. 36 (1): 33–9. PMID 16824795. doi:10.1016/j.hepres.2006.05.003.
Jump up ^ Williams KL, Rahimtula M, Mearow KM (2005). "Hsp27 and axonal growth in adult sensory neurons in vitro". BMC Neuroscience. 6 (1): 24. PMC 1087488  . PMID 15819993. doi:10.1186/1471-2202-6-24.
Jump up ^ "Soft tissue tumors: Pericytoma with t(7;12)". Atlas of Genetics and Cytogenetics in Oncology and Haematology. University Hospital of Poitiers. Retrieved 2013-01-21.
Jump up ^ Procaccio V, Salazar G, Ono S, Styers ML, Gearing M, Davila A, Jimenez R, Juncos J, Gutekunst CA, Meroni G, Fontanella B, Sontag E, Sontag JM, Faundez V, Wainer BH (Jun 2006). "A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia". American Journal of Human Genetics. 78 (6): 947–60. PMC 1474101  . PMID 16685646. doi:10.1086/504271.
Jump up ^ Nunoi H, Yamazaki T, Tsuchiya H, Kato S, Malech HL, Matsuda I, Kanegasaki S (Jul 1999). "A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection". Proceedings of the National Academy of Sciences of the United States of America. 96 (15): 8693–8. PMC 17578  . PMID 10411937. doi:10.1073/pnas.96.15.8693.
^ Jump up to: a b "Gene: ACTG1". AceView. U.S. National Center for Biotechnology Information (NCBI). Retrieved 2013-01-21.
Jump up ^ Erba HP, Gunning P, Kedes L (Jul 1986). "Nucleotide sequence of the human gamma cytoskeletal actin mRNA: anomalous evolution of vertebrate non-muscle actin genes". Nucleic Acids Research. 14 (13): 5275–94. PMC 311540  . PMID 3737401. doi:10.1093/nar/14.13.5275.
Jump up ^ Bryan KE, Rubenstein PA (Jul 2009). "Allele-specific effects of human deafness gamma-actin mutations (DFNA20/26) on the actin/cofilin interaction". The Journal of Biological Chemistry. 284 (27): 18260–9. PMC 2709362  . PMID 19419963. doi:10.1074/jbc.M109.015818.
Jump up ^ Sonnemann KJ, Fitzsimons DP, Patel JR, Liu Y, Schneider MF, Moss RL, Ervasti JM (Sep 2006). "Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy". Developmental Cell. 11 (3): 387–97. PMID 16950128. doi:10.1016/j.devcel.2006.07.001.
Jump up ^ Gouin E, Gantelet H, Egile C, Lasa I, Ohayon H, Villiers V, Gounon P, Sansonetti PJ, Cossart P (Jun 1999). "A comparative study of the actin-based motilities of the pathogenic bacteria Listeria monocytogenes, Shigella flexneri and Rickettsia conorii" (PDF). Journal of Cell Science. 112 (Pt 11): 1697–708. PMID 10318762.
Jump up ^ Lambrechts A, Gevaert K, Cossart P, Vandekerckhove J, Van Troys M (May 2008). "Listeria comet tails: the actin-based motility machinery at work". Trends in Cell Biology. 18 (5): 220–7. PMID 18396046. doi:10.1016/j.tcb.2008.03.001.
Jump up ^ Gouin E, Welch MD, Cossart P (Feb 2005). "Actin-based motility of intracellular pathogens". Current Opinion in Microbiology. 8 (1): 35–45. PMID 15694855. doi:10.1016/j.mib.2004.12.013.
Jump up ^ Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA (Apr 2009). "Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy". Journal of Medical Microbiology. 58 (Pt 4): 492–502. PMC 2677169  . PMID 19273646. doi:10.1099/jmm.0.005728-0.
Jump up ^ Liu Y, Belkina NV, Shaw S (2009). "HIV infection of T cells: actin-in and actin-out". Science Signaling. 2 (66): pe23. PMID 19366992. doi:10.1126/scisignal.266pe23.
Jump up ^ Machesky LM, Tang HR (Jul 2009). "Actin-based protrusions: promoters or inhibitors of cancer invasion?". Cancer Cell. 16 (1): 5–7. PMID 19573806. doi:10.1016/j.ccr.2009.06.009.
Jump up ^ Erickson HP (Jul 2007). "Evolution of the cytoskeleton". BioEssays. 29 (7): 668–77. PMC 2630885  . PMID 17563102. doi:10.1002/bies.20601.
Jump up ^ Gardiner J, McGee P, Overall R, Marc J (2008). "Are histones, tubulin, and actin derived from a common ancestral protein?". Protoplasma. 233 (1–2): 1–5. PMID 18615236. doi:10.1007/s00709-008-0305-z.
Jump up ^ Galletta BJ, Cooper JA (Feb 2009). "Actin and endocytosis: mechanisms and phylogeny". Current Opinion in Cell Biology. 21 (1): 20–7. PMC 2670849  . PMID 19186047. doi:10.1016/j.ceb.2009.01.006.
Jump up ^ Popp D, Narita A, Maeda K, Fujisawa T, Ghoshdastider U, Iwasa M, Maéda Y, Robinson RC (May 2010). "Filament structure, organization, and dynamics in MreB sheets". The Journal of Biological Chemistry. 285 (21): 15858–65. PMC 2871453  . PMID 20223832. doi:10.1074/jbc.M109.095901.
Jump up ^ van den Ent F, Amos LA, Löwe J (Sep 2001). "Prokaryotic origin of the actin cytoskeleton". Nature. 413 (6851): 39–44. PMID 11544518. doi:10.1038/35092500.
Jump up ^ Carballido-López R (Dec 2006). "The bacterial actin-like cytoskeleton". Microbiology and Molecular Biology Reviews. 70 (4): 888–909. PMC 1698507  . PMID 17158703. doi:10.1128/MMBR.00014-06.
Jump up ^ Popp D, Xu W, Narita A, Brzoska AJ, Skurray RA, Firth N, Ghoshdastider U, Goshdastider U, Maéda Y, Robinson RC, Schumacher MA (Mar 2010). "Structure and filament dynamics of the pSK41 actin-like ParM protein: implications for plasmid DNA segregation". The Journal of Biological Chemistry. 285 (13): 10130–40. PMC 2843175  . PMID 20106979. doi:10.1074/jbc.M109.071613.
Jump up ^ Popp D, Narita A, Ghoshdastider U, Maeda K, Maéda Y, Oda T, Fujisawa T, Onishi H, Ito K, Robinson RC (Apr 2010). "Polymeric structures and dynamic properties of the bacterial actin AlfA". Journal of Molecular Biology. 397 (4): 1031–41. PMID 20156449. doi:10.1016/j.jmb.2010.02.010.
Jump up ^ Popp D, Narita A, Lee LJ, Ghoshdastider U, Xue B, Srinivasan R, Balasubramanian MK, Tanaka T, Robinson RC (Jun 2012). "Novel actin-like filament structure from Clostridium tetani". The Journal of Biological Chemistry. 287 (25): 21121–9. PMC 3375535  . PMID 22514279. doi:10.1074/jbc.M112.341016.
Jump up ^ Hess H, Clemmens J, Qin D, Howard J, Vogel V (2001). "Light-controlled molecular shuttles made from motor proteins carrying cargo on engineered surfaces". Nano Letters. 1 (5): 235–239. doi:10.1021/nl015521e.
Jump up ^ Mansson A, Sundberg M, Bunk R, Balaz M, Nicholls IA, Omling P, Tegenfeldt JO, Tagerud S, Montelius L (2005). "Actin-Based Molecular Motors for Cargo Transportation in Nanotechnology—Potentials and Challenges". IEEE Transactions on Advanced Packaging. 28 (4): 547–555. doi:10.1109/TADVP.2005.858309. [dead link]
Jump up ^ Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (Jun 2002). "Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes". Genome Biology. 3 (7): RESEARCH0034. PMC 126239  . PMID 12184808. doi:10.1186/gb-2002-3-7-research0034.
Jump up ^ Selvey S, Thompson EW, Matthaei K, Lea RA, Irving MG, Griffiths LR (Oct 2001). "Beta-actin--an unsuitable internal control for RT-PCR". Molecular and Cellular Probes. 15 (5): 307–11. PMID 11735303. doi:10.1006/mcpr.2001.0376.
Jump up ^ Mukai K, Schollmeyer JV, Rosai J (Jan 1981). "Immunohistochemical localization of actin: applications in surgical pathology". The American Journal of Surgical Pathology. 5 (1): 91–7. PMID 7018275. doi:10.1097/00000478-198101000-00013.
Jump up ^ Haddad F, Roy RR, Zhong H, Edgerton VR, Baldwin KM (Aug 2003). "Atrophy responses to muscle inactivity. II. Molecular markers of protein deficits". Journal of Applied Physiology. 95 (2): 791–802. PMID 12716877. doi:10.1152/japplphysiol.01113.2002.
Jump up ^ Hocquette JF, Lehnert S, Barendse W, Cassar-Malek I, Picard B (2006). "Current advances in proteomic analysis and its use for the resolution of poultry meat quality". World's Poultry Science Journal. 62 (1): 123–130. doi:10.1079/WPS200589.
Jump up ^ Nollet L (2004). "Methods and Instruments in Applied Food Analysis". Handbook of food analysis. 3 (2 ed.). New York, N.Y: Marcel Dekker. pp. 1741–2226. ISBN 0-8247-5039-X.
External links[edit]
Actin Staining Techniques (Live and Fixed Cell Staining)
MBInfo - Actin Filaments (F-actin) grow from the polymerization of G-actin monomers
MBInfo - Actin Binding
MBInfo - Actin Nucleation
Eukaryotic Linear Motif resource motif class LIG_Actin_RPEL_3
Eukaryotic Linear Motif resource motif class LIG_Actin_WH2_1
Eukaryotic Linear Motif resource motif class LIG_Actin_WH2_2
3D macromolecular structures of actin filaments from the EM Data Bank(EMDB)
[show]
v
t
e
Proteins of the cytoskeleton
Human
Microfilaments
and ABPs
Myofilament
Actins
A1
A2
B
C1
G1
G2
Myosins
I
MYO1A
MYO1B
MYO1C
MYO1D
MYO1E
MYO1F
MYO1G
MYO1H)
II
MYH1
MYH2
MYH3
MYH4
MYH6
MYH7
MYH7B
MYH8
MYH9
MYH10
MYH11
MYH13
MYH14
MYH15
MYH16
III
MYO3A
MYO3B
V
MYO5A
MYO5B
MYO5C
VI
MYO6
VII
MYO7A
MYO7B
IX
MYO9A
MYO9B
X
MYO10
XV
MYO15A
XVIII
MYO18A
MYO18B
LC
MYL1
MYL2
MYL3
MYL4
MYL5
MYL6
MYL6B
MYL7
MYL9
MYLIP
MYLK
MYLK2
MYLL1
Other
Tropomodulin
1
2
3
4
Troponin
T 1 2 3
C 1 2
I 1 2 3
Tropomyosin
1
2
3
4
Actinin
1
2
3
4
Arp2/3 complex
actin depolymerizing factors
Cofilin
1
2
Destrin
Gelsolin
Profilin
1
2
Titin
Other
Wiskott-Aldrich syndrome protein
Fibrillin
Filamin
FLNA
FLNB
FLNC
Espin
TRIOBP
Intermediate
filaments
Type 1/2
(Keratin,
Cytokeratin)
Epithelial keratins
(soft alpha-keratins)
type I/chromosome 17
10
12
13
14
15
16
17
19
20
chromosome 12
18
none
21
type II/chromosome 12
1
2A
3
4
5
6A
6B
7
8
9
Hair keratins
(hard alpha-keratins)
type I/chromosome 17
31
32
33A
33B
34
35
36
37
38
type II/chromosome 12
81
82
83
84
85
86
Ungrouped alpha
chromosome 17
23
24
25
26
27
28
39
40
chromosome 12
71
72
73
74
75
76
77
78
79
80
Not alpha
Beta-keratin
Type 3
Desmin
GFAP
Peripherin
Vimentin
Type 4
Internexin
Nestin
Neurofilament
NEFL
NEFM
NEFH
Synemin
Syncoilin
Type 5
Nuclear lamins: A/C
B1
B2
Microtubules
and MAPs
Kinesins
KIF1A
KIF1B
KIF2A
KIF2C
KIF3B
KIF3C
KIF4A
KIF4B
KIF5A
KIF5B
KIF5C
KIF6
KIF7
KIF9
KIF11
KIF12
KIF13A
KIF13B
KIF14
KIF15
KIF16B
KIF17
KIF18A
KIF18B
KIF19
KIF20A
KIF20B
KIF21A
KIF21B
KIF22
KIF23
KIF24
KIF25
KIF26A
KIF26B
KIF27
KIFC1
KIFC2
KIFC3
Dyneins
axonemal: DNAH1
DNAH2
DNAH3
DNAH5
DNAH6
DNAH7
DNAH8
DNAH9
DNAH10
DNAH11
DNAH12
DNAH13
DNAH14
DNAH17
DNAI1
DNAI2
DNALI1
DNAL1
DNAL4
cytoplasmic: DYNC1H1
DYNC2H1
DYNC1I1
DYNC1I2
DYNC1LI1
DYNC1LI2
DYNC2LI1
DYNLL1
DYNLL2
DYNLRB1
DYNLRB2
DYNLT1
DYNLT3
Other
Tau protein
Dynactin
DCTN1
Tubulins
TUBA1A
TUBA1B
TUBA1C
TUBA3C
TUBA3D
TUBA3E
TUBA4A
TUBA8
Stathmin
Tektin
TEKT1
TEKT2
TEKT3
TEKT4
TEKT5
Dynamin
DNM1
DNM2
DNM3
Catenins
Alpha catenin
Beta catenin
APC
Plakoglobin (gamma catenin)
Delta catenin
GAN
Membrane
Dystrophin
Dystroglycan
Utrophin
Ankyrin
ANK1
ANK2
ANK3
Spectrin
SPTA1
SPTAN1
SPTB
SPTBN1
SPTBN2
SPTBN4
SPTBN5
Other
Plakins
Corneodesmosin
Desmoplakin
Dystonin
Envoplakin
MACF1
Periplakin
Plectin
Talin
TLN1
Vinculin
Plakophilin
PKP1
PKP2
Nonhuman
Major sperm proteins
Prokaryotic cytoskeleton
Crescentin
FtsZ
MreB
See also: cytoskeletal defects
[show]
v
t
e
Muscle tissue
Smooth
muscle
Calmodulin
Vascular smooth muscle
Striated
muscle
Skeletal
muscle
Costamere/
DAPC
Membrane/
extracellular
DAP:
Sarcoglycan
SGCA
SGCB
SGCD
SGCE
SGCG
SGCZ
Dystroglycan
Sarcospan
Laminin, alpha 2
Intracellular
Dystrophin
Dystrobrevin
A
B
Syntrophin
A
B1
B2
G1
G2
Syncoilin
Dysbindin
Synemin/desmuslin
related:
NOS1
Caveolin 3
Sarcomere/
(a, i, and h bands;
z and m lines)
Myofilament
thin filament/actin
thick filament/myosin
elastic filament/titin
nebulin
Tropomyosin
Troponin
T
C
I
Connective tissue
Epimysium
Fascicle
Perimysium
Endomysium
Connective tissue in skeletal muscle
General
Neuromuscular junction
Motor unit
Muscle spindle
Excitation–contraction coupling
Sliding filament mechanism
Cardiac
muscle
Myocardium
Intercalated disc
Nebulette
Both
Fiber
Muscle fiber
intrafusal
extrafusal
Myofibril
Microfilament/Myofilament
Sarcomere
Cells
Myoblast/Myocyte
Myosatellite cell
Other
Desmin
Sarcoplasm
Sarcolemma
T-tubule
Sarcoplasmic reticulum
Other/
ungrouped
Myotilin
Telethonin
Dysferlin
Fukutin
Fukutin-related protein
[show]
v
t
e
Antigens: Autoantigens
Dehydrogenase
Branched-chain alpha-keto acid dehydrogenase complex
Oxoglutarate dehydrogenase
Pyruvate dehydrogenase
Transglutaminase
Epidermal transglutaminase
Tissue transglutaminase
Nucleoporins
NUP35
NUP37
NUP43
NUP50
NUP54
NUP62
NUP85
NUP88
NUP93
NUP98
NUP107
NUP133
NUP153
NUP155
NUP160
NUP188
NUP210
NUP205
NUP214
Other
Acetylcholine receptor
Actin
Apolipoprotein H
Cardiolipin
Centromere
Filaggrin (Citrullinate)
Gangliosides
Sp100 nuclear antigen
Thrombin
Topoisomerase
Retrieved from "https://en.wikipedia.org/w/index.php?title=Actin&oldid=797884964"
Categories:
Cytoskeleton
Structural proteins
Autoantigens
Hidden categories:
Pages with DOIs inactive since 2017
CS1 Spanish-language sources (es)
All articles with dead external links
Articles with dead external links from August 2013
All articles with unsourced statements
Articles with unsourced statements from July 2015
Articles containing video clips
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
In other projects
Wikimedia Commons
Languages
العربية
Български
Bosanski
Català
Čeština
Dansk
Deutsch
Eesti
Español
Euskara
فارسی
Français
Gaeilge
Galego
Հայերեն
Hrvatski
Bahasa Indonesia
Italiano
עברית
Basa Jawa
Қазақша
Kreyòl ayisyen
Кыргызча
Lietuvių
Nederlands
日本語
Norsk nynorsk
Occitan
Polski
Português
Română
Русский
Shqip
Slovenčina
کوردی
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
Svenska
Tagalog
ไทย
Türkçe
Українська
Tiếng Việt
中文
Edit links
This page was last edited on 29 August 2017, at 18:51.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

values: mw-page-base noprint

values: mw-head-base noprint

attrs: id class style

values: firstHeading firstHeading en

values: siteSub noprint

values: jump-to-nav mw-jump

value: sup

values:
nofollow
external text
http://pfam.xfam.org/family?acc=PF00022

values: background-color: #e7dcc3; border:#fafafa 2px solid; border-width:3px 2px 0 0;

values: background-color: #eee; border:#fafafa 2px solid; border-width:3px 0 0 2px;

values: width:22em;float:none; clear:none; margin:0; border-width:0; border-collapse:collapse; text-align:left; width:100%

values:
/wiki/Chemical_mediator
mw-redirect
Chemical mediator

values:
/wiki/Molecular_motors
mw-redirect
Molecular motors

values:
/wiki/Prokaryotic_cells
mw-redirect
Prokaryotic cells

values: Edit section: Discovery and early investigation

values:
/wiki/W.D._Halliburton
mw-redirect
W.D. Halliburton

values:
/wiki/Western_countries
mw-redirect
Western countries

values:
/wiki/Smooth_muscle
mw-redirect
Smooth muscle

values:
/wiki/Peptide_sequence
mw-redirect
Peptide sequence

values:
/wiki/Amino_acid_sequence
mw-redirect
Amino acid sequence

values:
/wiki/Protein-protein_interaction
mw-redirect
Protein-protein interaction

values:
/wiki/Stress_fibre
mw-redirect
Stress fibre

values:
/wiki/Dalton_(unit)
mw-redirect
Dalton (unit)

values:
/wiki/Enzyme_substrate_(biology)
mw-redirect
Enzyme substrate (biology)

values: This claim needs references to reliable sources. (July 2015)

values:
noprint Inline-Template Template-Fact
white-space:nowrap;

values:
/wiki/CAP_(protein)
mw-redirect
CAP (protein)

values: Edit section: ATPase’s catalytic mechanism

values: Adherens Junctions structural proteins.svg

values:
/wiki/Conservation_(genetics)
mw-redirect
Conservation (genetics)

values:
/wiki/Primary_structure
mw-redirect
Primary structure

values:
/wiki/Translation_(genetics)
mw-redirect
Translation (genetics)

values: Edit section: Nucleation and polymerization

values:
/wiki/Noncovalent_bonding
mw-redirect
Noncovalent bonding

values:
/wiki/Protein_conformation
mw-redirect
Protein conformation

values:
/wiki/Vesicle_(biology)
mw-redirect
Vesicle (biology)

values:
/wiki/Muscle_fibre
mw-redirect
Muscle fibre

values:
/wiki/Animal_cell
mw-redirect
Animal cell

values:
/wiki/Sodium_ion_channel
mw-redirect
Sodium ion channel

values:
/wiki/Adenylate_cyclase
mw-redirect
Adenylate cyclase

values:
/wiki/Plant_cell_wall
mw-redirect
Plant cell wall

values: Edit section: Transport of actin through the nuclear membrane

values: Edit section: The organization of nuclear actin

values: Edit section: Actin isoforms in the cell nucleus

values:
/wiki/Muscular_contraction
mw-redirect
Muscular contraction

values: Edit section: Outline of a muscle contraction

values:
/wiki/Plasma_membrane
mw-redirect
Plasma membrane

values: Edit section: Actin’s role in muscle contraction

values: Edit section: Other biological processes

values: <video id="mwe_player_1" poster="//upload.wikimedia.org/wikipedia/commons/thumb/3/3f/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv/352px--Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv.jpg" controls="" preload="none" autoplay="" style="width:352px;height:364px" class="kskin" data-durationhint="22.625" data-startoffset="0" data-mwtitle="Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv" data-mwprovider="wikimediacommons"><source src="//upload.wikimedia.org/wikipedia/commons/3/3f/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv" type="video/ogg; codecs="theora"" data-title="Original Ogg file, 352 × 364 (506 kbps)" data-shorttitle="Ogg source" data-width="352" data-height="364" data-bandwidth="505552" data-framerate="8"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/3/3f/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv.160p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Low bandwidth WebM (160P)" data-shorttitle="WebM 160P" data-transcodekey="160p.webm" data-width="154" data-height="160" data-bandwidth="127592" data-framerate="8"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/3/3f/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv.240p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="Small WebM (240P)" data-shorttitle="WebM 240P" data-transcodekey="240p.webm" data-width="232" data-height="240" data-bandwidth="256776" data-framerate="8"/><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/3/3f/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv/Diverse-roles-of-actin-in-C.-elegans-early-embryogenesis-1471-213X-7-142-S9.ogv.360p.webm" type="video/webm; codecs="vp8, vorbis"" data-title="WebM (360P)" data-shorttitle="WebM 360P" data-transcodekey="360p.webm" data-width="348" data-height="360" data-bandwidth="510488" data-framerate="8"/></video>

values:
/wiki/Zonula_occludens
mw-redirect
Zonula occludens

values:
/wiki/Cellular_adhesion
mw-redirect
Cellular adhesion

values:
/wiki/Multicellular_organisms
mw-redirect
Multicellular organisms

values:
/wiki/Skeletal_striated_muscle
mw-redirect
Skeletal striated muscle

values: Edit section: Pathology associated with ACTA1

values:
/wiki/DNA_sequence
mw-redirect
DNA sequence

values:
/wiki/Transcription_(genetics)
mw-redirect
Transcription (genetics)

values:
/wiki/Genetic_mutation
mw-redirect
Genetic mutation

values:
/wiki/Aortic_aneurism
mw-redirect
Aortic aneurism

values:
/wiki/Ischaemic_heart_disease
mw-redirect
Ischaemic heart disease

values:
/wiki/Protein_domains
mw-redirect
Protein domains

values:
/wiki/Stress_(physiology)
mw-redirect
Stress (physiology)

values:
/wiki/Neutrophil_granulocyte
mw-redirect
Neutrophil granulocyte

values: Edit section: Other pathological mechanisms

values:
/wiki/Quantitative_PCR
mw-redirect
Quantitative PCR

values: div-col columns column-count column-count-2

values: -moz-column-count: 2; -webkit-column-count: 2; column-count: 2;

values:
/wiki/PubMed_Identifier
mw-redirect
PubMed Identifier

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11474115

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1059700

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18573073

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23904035

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25788699

values:
nofollow
external text
//doi.org/10.1242%2Fjcs.165563

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26178194

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.1511568112

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16991477

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/2673365

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11602582

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/4517681

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.70.9.2687

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/2395459

values:
nofollow
external text
//doi.org/10.1038%2F347037a0

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/2395461

values:
nofollow
external text
//doi.org/10.1038%2F347044a0

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/320040

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18391412

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17110933

values:
nofollow
external text
//doi.org/10.1038%2Fsj.emboj.7601395

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19158791

values:
nofollow
external text
//doi.org/10.1038%2Fnature07685

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25470062

values:
nofollow
external text
//doi.org/10.1038%2Fnature14033

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6842590

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6646124

values:
nofollow
external text
//doi.org/10.1128%2FMCB.3.10.1783

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17189356

values:
nofollow
external text
//doi.org/10.1128%2FJB.01454-06

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12813032

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M303689200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8448029

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1150665

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16920713

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M601973200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17965017

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.R700030200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/569662

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.79.3.846

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14634002

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M306053200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12456645

values:
nofollow
external text
//doi.org/10.1093%2Femboj%2Fcdf640

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19393268

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18595008

values:
nofollow
external text
//doi.org/10.1007%2Fs12192-008-0057-x

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16415341

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M513235200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10209023

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.145.2.265

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17304242

values:
nofollow
external text
//doi.org/10.1038%2Fsj.embor.7400894

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16300788

values:
nofollow
external text
//doi.org/10.1016%2Fj.jmb.2005.10.051

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15939882

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.0501435102

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/745245

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11061563

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17332412

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1138527

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/5463781

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15111391

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6893454

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.86.1.330

values:
nofollow
external text
//doi.org/10.1007%2Fs12195-011-0181-z

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22246323

values:
nofollow
external text
//doi.org/10.1038%2Fnature10745

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8413665

values:
nofollow
external text
//doi.org/10.1038%2F365810a0

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15501675

values:
nofollow
external text
//doi.org/10.1016%2Fj.tibs.2004.09.004

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1330091

values:
nofollow
external text
//doi.org/10.1091%2Fmbc.3.9.1015

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9463375

values:
nofollow
external text
//doi.org/10.1093%2Femboj%2F17.4.967

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/563468

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12655044

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.0736004100

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24155256

values:
nofollow
external text
//doi.org/10.1002%2Fcm.21149

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10860951

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.97.13.6936

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/2557904

values:
nofollow
external text
//doi.org/10.1021%2Fbi00447a036

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/7798317

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.127.6.1627

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11721045

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1066333

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10322212

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10047519

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10854330

values:
nofollow
external text
//doi.org/10.1038%2F35014075

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/3312229

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.105.4.1473

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9688570

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24748680

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16495046

values:
nofollow
external text
//doi.org/10.1016%2Fj.gde.2006.02.001

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15769249

values:
nofollow
external text
//doi.org/10.1042%2FBJ20050085

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23239625

values:
nofollow
external text
//doi.org/10.1126%2Fscience.1232251

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16959963

values:
nofollow
external text
//doi.org/10.1128%2FMMBR.00013-06

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10368172

values:
nofollow
external text
//doi.org/10.1105%2Ftpc.11.6.995

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15096633

values:
nofollow
external text
//doi.org/10.1110%2Fps.03518104

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17936064

values:
nofollow
external text
//doi.org/10.1016%2Fj.pbi.2007.08.012

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11123801

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/563771

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19215906

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16489345

values:
nofollow
external text
//doi.org/10.1038%2Fncb1357

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22323606

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.1118880109

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9501085

values:
nofollow
external text
//doi.org/10.1093%2Femboj%2F17.6.1635

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/14592989

values:
nofollow
external text
//doi.org/10.1093%2Femboj%2Fcdg565

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19635839

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.200905016

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15994898

values:
nofollow
external text
//doi.org/10.1529%2Fbiophysj.105.062083

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16476775

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.200507101

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16828286

values:
nofollow
external text
//doi.org/10.1016%2Fj.tcb.2006.06.006

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26239425

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12490148

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20308063

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M110.110130

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22046450

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9845365

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15502823

values:
nofollow
external text
//doi.org/10.1038%2Fncb1182

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15574586

values:
nofollow
external text
//doi.org/10.1101%2Fgad.1250804

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15558034

values:
nofollow
external text
//doi.org/10.1038%2Fncb1190

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15581488

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22448045

values:
nofollow
external text
//doi.org/10.1074%2Fmcp.M111.015099

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15328537

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21496632

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18442483

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16103215

values:
nofollow
external text
//doi.org/10.1101%2Fgad.339405

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16549500

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.200512083

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18718493

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20593452

values:
nofollow
external text
//doi.org/10.1002%2Fcm.20464

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12045110

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19459931

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19477923

values:
nofollow
external text
//doi.org/10.1091%2Fmbc.E09-02-0114

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20053683

values:
nofollow
external text
//doi.org/10.1091%2Fmbc.E09-06-0534

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21536734

values:
nofollow
external text
//doi.org/10.1101%2Fgad.615211

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21331046

values:
nofollow
external text
//doi.org/10.1038%2Fnature09703

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22046469

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16631592

values:
nofollow
external text
//doi.org/10.1016%2Fj.cub.2006.03.059

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16960872

values:
nofollow
external text
//doi.org/10.1002%2Fjcb.21035

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20414257

values:
nofollow
external text
//doi.org/10.1038%2Fnrm2890

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12732141

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18423404

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20370316

values:
nofollow
external text
//doi.org/10.1515%2FBC.2010.061

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/359574

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.79.1.268

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12214236

values:
nofollow
external text
//doi.org/10.1038%2Fnature00999

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9070648

values:
nofollow
external text
//doi.org/10.1038%2Fsj.onc.1200919

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10631785

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9472000

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9832563

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.143.5.1361

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8991100

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.135.6.1899

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1732064

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8987752

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17715368

values:
nofollow
external text
//doi.org/10.1128%2FEC.00188-07

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12672658

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8598290

values:
nofollow
external text
//doi.org/10.1101%2Fgad.10.5.604

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18692583

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15024034

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.200310055

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17517645

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.0703153104

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20123994

values:
nofollow
external text
//doi.org/10.1083%2Fjcb.200906043

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21709270

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.1103834108

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15075390

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.0400782101

values:
nofollow
external text
http://www.uniprot.org/uniprot/P68133

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17227580

values:
nofollow
external text
//doi.org/10.1186%2F1471-2121-8-2

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15520409

values:
nofollow
external text
//doi.org/10.1136%2Fjmg.2004.020271

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12921789

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15198992

values:
nofollow
external text
//doi.org/10.1093%2Fhmg%2Fddh185

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17387733

values:
nofollow
external text
//doi.org/10.1002%2Fana.21112

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1710027

values:
nofollow
external text
//doi.org/10.1128%2Fmcb.11.6.3296

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17562441

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17994018

values:
nofollow
external text
//doi.org/10.1038%2Fng.2007.6

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19409525

values:
nofollow
external text
//doi.org/10.1016%2Fj.ajhg.2009.04.007

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16115228

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6310553

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.79.19.5901

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/9563954

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16450009

values:
nofollow
external text
https://omim.org/entry/102540

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17947298

values:
nofollow
external text
//doi.org/10.1093%2Fhmg%2Fddm302

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10966831

values:
nofollow
external text
//doi.org/10.1006%2Fjmcc.2000.1204

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18467357

values:
nofollow
external text
//doi.org/10.1136%2Fhrt.2007.134684

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1850600

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16824795

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15819993

values:
nofollow
external text
//doi.org/10.1186%2F1471-2202-6-24

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16685646

values:
nofollow
external text
//doi.org/10.1086%2F504271

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10411937

values:
nofollow
external text
//doi.org/10.1073%2Fpnas.96.15.8693

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/3737401

values:
nofollow
external text
//doi.org/10.1093%2Fnar%2F14.13.5275

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19419963

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M109.015818

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16950128

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10318762

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18396046

values:
nofollow
external text
//doi.org/10.1016%2Fj.tcb.2008.03.001

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15694855

values:
nofollow
external text
//doi.org/10.1016%2Fj.mib.2004.12.013

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19273646

values:
nofollow
external text
//doi.org/10.1099%2Fjmm.0.005728-0

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19366992

values:
nofollow
external text
//doi.org/10.1126%2Fscisignal.266pe23

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19573806

values:
nofollow
external text
//doi.org/10.1016%2Fj.ccr.2009.06.009

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17563102

values:
nofollow
external text
//doi.org/10.1002%2Fbies.20601

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18615236

values:
nofollow
external text
//doi.org/10.1007%2Fs00709-008-0305-z

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19186047

values:
nofollow
external text
//doi.org/10.1016%2Fj.ceb.2009.01.006

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20223832

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M109.095901

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11544518

values:
nofollow
external text
//doi.org/10.1038%2F35092500

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17158703

values:
nofollow
external text
//doi.org/10.1128%2FMMBR.00014-06

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20106979

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M109.071613

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20156449

values:
nofollow
external text
//doi.org/10.1016%2Fj.jmb.2010.02.010

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22514279

values:
nofollow
external text
//doi.org/10.1074%2Fjbc.M112.341016

values:
nofollow
external text
//doi.org/10.1021%2Fnl015521e

values:
nofollow
external text
//doi.org/10.1109%2FTADVP.2005.858309

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12184808

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11735303

values:
nofollow
external text
//doi.org/10.1006%2Fmcpr.2001.0376

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/7018275

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12716877

values:
nofollow
external text
//doi.org/10.1079%2FWPS200589

values: -moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;

values:
nofollow
external text
http://www.pdbe.org/emsearch/actin*

values:
/wiki/Actinin,_alpha_1
mw-redirect
Actinin, alpha 1

values:
/wiki/Actinin,_alpha_2
mw-redirect
Actinin, alpha 2

values:
/wiki/CFL2_(gene)
mw-redirect
CFL2 (gene)

values:
/wiki/Wiskott-Aldrich_syndrome_protein
mw-redirect
Wiskott-Aldrich syndrome protein

values:
/wiki/Epithelial_keratin
mw-redirect
Epithelial keratin

values:
/wiki/Chromosome_17
mw-redirect
Chromosome 17

values:
/wiki/Chromosome_12
mw-redirect
Chromosome 12

values:
/wiki/Talin_(protein)
mw-redirect
Talin (protein)

values: nowraplinks hlist collapsible collapsed navbox-inner

values:
/wiki/Sliding_filament_mechanism
mw-redirect
Sliding filament mechanism

values: nowraplinks collapsible autocollapse navbox-inner

values: Branched-chain alpha-keto acid dehydrogenase complex

values:
/wiki/Oxoglutarate_dehydrogenase
mw-redirect
Oxoglutarate dehydrogenase

values: Category:Pages with DOIs inactive since 2017

values: Category:CS1 Spanish-language sources (es)

values: Category:All articles with dead external links

values: Category:Articles with dead external links from August 2013

values: Category:All articles with unsourced statements

values: Category:Articles with unsourced statements from July 2015

values: Category:Articles containing video clips

values: Discussion about edits from this IP address [ctrl-alt-n]

values: A list of edits made from this IP address [ctrl-alt-y]

values: You are encouraged to create an account and log in; however, it is not mandatory

values: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

values:
/wiki/Actin
View the content page [ctrl-alt-c]
c

values: Discussion about the content page [ctrl-alt-t]

values: p-namespaces navigation vectorTabs p-namespaces-label

values:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

values:
/w/index.php?title=Actin&action=edit
Edit this page [ctrl-alt-e]
e

values: Past revisions of this page [ctrl-alt-h]

values: p-views navigation vectorTabs p-views-label

values:
p-cactions
navigation
vectorMenu emptyPortlet
p-cactions-label

values:
mw-wiki-logo
/wiki/Main_Page
Visit the main page

values:
/wiki/Main_Page
Visit the main page [ctrl-alt-z]
z

values: Featured content – the best of Wikipedia

values: Find background information on current events

values:
/wiki/Special:Random
Load a random article [ctrl-alt-x]
x

values: portal navigation p-navigation p-navigation-label

values: Guidance on how to use and edit Wikipedia

values: portal navigation p-wikibase-otherprojects p-wikibase-otherprojects-label

values:
uls-settings-trigger
Language settings
0
button
true

values: أكتين – Arabic

values:
https://bs.wikipedia.org/wiki/Aktin
Aktin – Bosnian
bs
bs
interlanguage-link-target

values:
https://ca.wikipedia.org/wiki/Actina
Actina – Catalan
ca
ca
interlanguage-link-target

values: interlanguage-link interwiki-ca badge-Q17437796 badge-featuredarticle

values:
https://cs.wikipedia.org/wiki/Aktin
Aktin – Czech
cs
cs
interlanguage-link-target

values:
https://da.wikipedia.org/wiki/Actin
Actin – Danish
da
da
interlanguage-link-target

values:
https://de.wikipedia.org/wiki/Aktin
Aktin – German
de
de
interlanguage-link-target

values:
https://et.wikipedia.org/wiki/Aktiin
Aktiin – Estonian
et
et
interlanguage-link-target

values:
https://es.wikipedia.org/wiki/Actina
Actina – Spanish
es
es
interlanguage-link-target

values: interlanguage-link interwiki-es badge-Q17437796 badge-featuredarticle

values:
https://eu.wikipedia.org/wiki/Aktina
Aktina – Basque
eu
eu
interlanguage-link-target

values:
https://fr.wikipedia.org/wiki/Actine
Actine – French
fr
fr
interlanguage-link-target

values:
https://ga.wikipedia.org/wiki/Aictin
Aictin – Irish
ga
ga
interlanguage-link-target

values:
https://gl.wikipedia.org/wiki/Actina
Actina – Galician
gl
gl
interlanguage-link-target

values:
https://hr.wikipedia.org/wiki/Aktin
Aktin – Croatian
hr
hr
interlanguage-link-target

values:
https://id.wikipedia.org/wiki/Aktin
Aktin – Indonesian
id
id
interlanguage-link-target

values:
https://it.wikipedia.org/wiki/Actina
Actina – Italian
it
it
interlanguage-link-target

values: אקטין – Hebrew

values:
https://jv.wikipedia.org/wiki/Aktin
Aktin – Javanese
jv
jv
interlanguage-link-target

values: Актин – Kazakh

values:
https://ht.wikipedia.org/wiki/Aktin
Aktin – Haitian Creole
ht
ht
interlanguage-link-target

values: Актин – Kyrgyz

values:
https://lt.wikipedia.org/wiki/Aktinas
Aktinas – Lithuanian
lt
lt
interlanguage-link-target

values:
https://nl.wikipedia.org/wiki/Actine
Actine – Dutch
nl
nl
interlanguage-link-target

values:
https://nn.wikipedia.org/wiki/Aktin
Aktin – Norwegian Nynorsk
nn
nn
interlanguage-link-target

values:
https://oc.wikipedia.org/wiki/Actina
Actina – Occitan
oc
oc
interlanguage-link-target

values:
https://pl.wikipedia.org/wiki/Aktyna
Aktyna – Polish
pl
pl
interlanguage-link-target

values:
https://pt.wikipedia.org/wiki/Actina
Actina – Portuguese
pt
pt
interlanguage-link-target

values:
https://sq.wikipedia.org/wiki/Aktini
Aktini – Albanian
sq
sq
interlanguage-link-target

values: Актински филаменти – Serbian

values:
https://fi.wikipedia.org/wiki/Aktiini
Aktiini – Finnish
fi
fi
interlanguage-link-target

values:
https://sv.wikipedia.org/wiki/Aktin
Aktin – Swedish
sv
sv
interlanguage-link-target

values:
https://tl.wikipedia.org/wiki/Actin
Actin – Tagalog
tl
tl
interlanguage-link-target

values: แอกติน – Thai

values:
https://tr.wikipedia.org/wiki/Aktin
Aktin – Turkish
tr
tr
interlanguage-link-target

values: /static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x

values: /static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x

values:
suggestions
display: none; font-size: 13px;

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Actin rootpage-Actin skin-vector action-view